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In 2012, Amagata et al. isolated a natural product from a marine-derived actinomycetes. The 
compound exhibited human class III HDAC (SIRT) inhibition and was named streptosetin A. 
Structurally, streptosetin A is categorized as a polyketide tetramic acid derivative, produced 
by an NRPS−PKS hybrid pathway, as reported for equisetin isolated from a Fusarium equiseti. 
This thesis describes the research efforts toward the synthesis of the decalin core of 
streptosetin A. An asymmetric synthesis of the key enone was achieved in a five-step 
sequence. The enantioenriched enone core was formed in 79% ee. The synthetic route 
involved the Diels-Alder cycloaddition reaction of Rawal’s diene with a dienophile to generate 
a Diels-Alder product. Thereafter, the reduction and removal of the OTBS protection group, 
together with the elimination of dimethylamine afforded an enone compound. Further 
studies on Diels-Alder and Sakurai reactions were undertaken in an attempt to secure the 










































Scheme 1. Formation of the decalin core of streptosetin A 
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8. Introduction 
8.1 Decalin rings in natural products 
A natural product is a substance or chemical compound that is produced by a living organism 
in nature, and many of these are biologically active. Many bioactive compounds are secondary 
metabolites produced by the microorganisms for their defence, detoxification, or 
communication with other organisms.1,2 Natural products can be prepared by chemical 
synthesis, and this has historically played an important role in the development of the field of 
organic chemistry.3,4 
The decalin motif is found in several secondary metabolites produced by microorganisms, 
mainly fungi and actinomycetes.5 It is typically connected to highly multi-functionalized or 
complex groups, resulting in high structural and functional diversity.  
 
Figure 1. Structures of trans-decalin (1) and cis-decalin (2). 
Decalin (Figure 1) is a fused bicyclic, saturated hydrocarbon (bicyclo[4.4.0]decane). Decalin 
can exist in two configurations, trans-decalin (1) and cis-decalin (2). The ring-junction 
hydrogens on the same side of the molecule form cis-decalin, while those on the opposite 
sides form trans-decalin. In trans-decalin, the two rings are joined through two equatorial 
bonds. On the other hand, in cis-decalin, the two rings are joined by axial and equatorial 
bonds. These units are present in many natural products such as those shown in Figure 2. 




Figure 2. Chemical structures of streptosetin A (3),9 anthracimycin (4),10 platensimycin (5),11 
myceliothermophin E (6),12 and popolohuanone E (7).13  
These compounds show various biological activities including antifungal, antibacterial, 
anticancer, and immunosuppressive activities, and have attracted considerable interest from 
researchers worldwide in terms of their biosyntheses, chemical syntheses, and varying the 
properties of the functionalized decalin motif (Figure 2).6–8  For example Streptosetin A (3)9 
shows anticancer properties, anthracimycin (4)10  and platensimycin (5)11  are antibiotics, 
Myceliothermophin E (6)12 shows potent cytotoxic activity against the Chinese hamster ovary 
cell line, and Popolohuanone E (7)13 shows highly selective cytotoxicity against the A549 
human non-small cell lung cancer cells. 
Streptosetin A 3 was isolated from a yeast and was identified during the screening of the 
extract libraries of marine-derived actinomycetes. Streptosetin A shows weak inhibitory 
activity against yeast Sir2p as well as human SIRT1 and SIRT2.9 
In 2013, Fenical et al. reported the isolation of a natural product from a marine microorganism 
of streptomyces species collected from the deep ocean near Santa Barbara, CA, which showed 
noteworthy activity against Bacillus anthracis as well as vancomycin resistant and methicillin-
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resistant Staphylococcus aureus (MRSA).10 The compound was a potent antibiotic and was 
identified as 14-6-6 membered ring polyketide macrolide 410 (Figure 2). 
Platensimycin 511 is a potent bacterial type II fatty acid biosynthesis inhibitor, which was 
isolated from various strains of Streptomyces platensis, that were obtained from the soil 
samples collected in South Africa and Spain. This natural product selectively inhibits S. aureus 
FabF. This enzyme catalyses the initial condensation step in bacterial fatty acid synthesis.14 It 
is an antibiotic that is biologically active against gram-positive pathogens, including 
methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus 
(VRE) with no observed toxicity.  
Myceliothermophin E 612 is a new polyketide that contains a tetramic acid, and was isolated 
from thermophilic fungus, Myceliophthora thermophila.12 Five analogues containing tetramic 
acid moieties, myceliothermophins A–E, were isolated, through bioassay-guided separation. 
The cytotoxicity assays of myceliothermophins A–E against four types of cancer cells, human 
hepatoblastoma (HepG2), human hepatocellular carcinoma (Hep3B), human lung carcinoma 
(A-549), and human breast adenocarcinoma (MCF-7) have been reported. 
Popolohuanone E 713 was isolated from the Dysidea sp. of Pohnpei marine sponge by Scheuer 
et al. in 1993. It is a potent inhibitor of topoisomerase II and shows highly selective 
cytotoxicity against the A549 human non-small cell lung cancer cells.13,15,16 
The above compounds are examples of naturally occurring complex decalin systems. These 
decalin cores have different functionalized moieties such as macrolide ring, tetramic acid, 
aminobenzoic acid units and benzofuran derivatives, affording different biological activities. 
As these compounds are only available in small quantities from natural sources, the total 
synthesis of the natural products is important for further investigation of their biological 
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8.2 Total synthesis of natural products. 
Primary metabolism is the biosynthesis and breakdown of proteins, fats, nucleic acids and 
carbohydrates, which are essential for all living organisms. The compounds involved in this 
process are called primary metabolites.17 Secondary metabolites (natural products) are 
typically organic compounds produced by the modification of primary metabolite 
biosynthesis. Secondary metabolites are not essential for the growth, development, or 
reproduction of a living organism,17,18 but they are produced for defence against predators or 
adaptation to the surrounding environment.17,19  
Natural products have been traditionally used for the treatment of many diseases and 
illnesses, and play a significant role in drug discovery and development.20 Many of these 
natural products have afforded current drug candidates. 20,21 The most well-known example 
is the synthesis of an anti-inflammatory agent, acetylsalicylic acid (aspirin), derived from 
salicin, which is a natural product isolated from the bark of the willow tree, Salix alba L.22 
Morphine isolated from the plant, P. somniferum, is treated with acetic anhydride to yield 
diacetylmorphine (heroin), which is used as a painkiller.  
The isolation of natural products and investigation of their biological activities is possible, but 
the quantities are not sufficient for their use in medicinal purposes. Hence, the role of total 
synthesis in the development of natural products is very important.23 Total synthesis is the 
chemical synthesis of a molecule, starting from simple, readily available building blocks. 
8.3 Biosynthesis of polyketide decalins  
Polyketide synthase (PKS) is an enzyme that produces polyketides, and is divided into three 
classes: type I, iterative type II, and acyl-carrier protein type III. Type I PKSs comprise β-
ketoacyl-ACP synthase, acyltransferase, and acyl carrier protein domains, and are used to 
select and load carboxylic acid units for condensation in the chain assembly.24  
For the biosynthesis of the anthracimycin polyketide 4, the enzyme responsible for type I 
polyketide synthase (PKS) was identified,25 and it was determined that for the synthesis of the 
intermediates in the chain elongation process, type I polyketide synthase (PKS) catalysed a 
series of Claisen-like condensations (Scheme 2).24 
The route for the biosynthesis of anthracimycin 4 may be initiated by the decarboxylation of 
malonyl residue 8 and addition to acyl CoA, followed by reduction to form the acylated ACP1 
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metabolite intermediate 9.26,27 ACP2 10 was formed by chain elongation via the addition of  a 
β,γ-double bond, formed by a series of addition, reduction, and elimination steps, which could 
also be introduced in fragment 11 to form a conjugated diene. During the process of chain 
elongation with the introduction of α,β-double bonds to form fragment 12, modules 10 and 
11 could be characterised.27  In the next step, the formation of intermediate 14 involved α-
methylation and β-keto reduction. After this, a β,γ -shift would occur to install a double bond 
with cis-geometry.28 The α,β-unsaturated compound 16 was formed by further chain 
elongation, and was suitable for the Diels-Alder [4 + 2] cycloaddition, to generate the trans-
decalin motif of the natural product. An endo-transition state could be envisioned to form 
this trans-decalin core. The last two-step sequence of chain elongation would be 
characterised by a thioesterase (TE) domain to catalyse the macrocyclization and chain 
release (Scheme 2).25  
The enzymes capable of catalysing [4 + 2] cycloadditions have been characterized for a small 
number of natural product biosynthetic pathways, for the formation trans-decalin 
scaffolds.29-35 Recently, in the biosynthetic pathway of pyrroindomycin, Liu and coworkers 
identified that an FAD-dependent enzyme PyrE3 could catalyse the formation of the trans-
decalin moiety of this molecule.36 In addition, in the biosynthesis of the fungal metabolite, 
lovastatin, the LovB PKS enzyme is responsible for the [4+2] cycloaddition which generates 
the trans-declain product.33,34,37 In the biosynthesis of 4, it is unknown if the intramolecular 
Diels-Alder reaction is catalysed by an enzyme or is spontaneous to form the trans-decalin 
system. In this cycloaddition, intermediate 16 has a trans-geometry dienophile double bond 
and a rigidity and orientation, imparted by the presence of two β,γ-shifted double bonds. This 
decreases the degree of freedom and assists this intramolecular cycloaddition by steric effects 
rather than being stabilised by any particular transition state explanation.25 
 










































































ActD module1 ActD module2 ActD module3
ActD module4 ActD module5 ActD module6/7
























19 | P a g e  
 
8.4 Chemical syntheses of decalin-cores of natural product 
Many natural products such as isoprenoids and polyketides contain the decalin ring system. 
This motif can be multifunctionalised with the attachment of complex groups, and owing to 
the diversity of structures, diverse biological activities are observed. Therefore, many 
researchers worldwide are investigating their chemical syntheses and therapeutic potential. 
The decalin system has two fused rings, and several methods have been used for its 
synthesis.38 The chemical syntheses of decalins mainly involve (a) inter and intramolecular 
Diels-Alder reactions, (b) nucleophilic and anionic cyclisations, and (c) cation- or radical-
induced polyene cyclisations. The chemical syntheses of the decalin cores of a few natural 
products are discussed below.  
8.4.1 Chemical synthesis of decalin core by Diels-Alder reactions  
The Diels–Alder cycloaddition is often used for the syntheses of six-membered cyclic 
compounds. Intermolecular and intramolecular Diels-Alder reactions are the two types that 
can be used to synthesize the decalin structures. 
Intermolecular Diels-Alder reaction 
The intermolecular Diels–Alder reaction has been widely applied to the construction of cis-
decalin frameworks. The tricyclic ent-kaurenoid 22 was synthesised by intermolecular Diels-
Alder cycloaddition. In this reaction, a mild Lewis acid was used for the σ- complex formation 
with enone 20, which was then reacted with diene 21 to form Diels -Alder cycloaddition 
product 23. Then, a π-complex was formed with alkyne intermediate 23, which underwent 
carbocyclisation, via, the breakage of the silyl enol ether bond (O-Si bond) leading to tricyclic 
product 22.39 This cyclic product 22 was used as a building block for the synthesis of 
platensimycin 511 (Scheme 3). 
 



































Scheme 3. Intermolecular Diels-Alder/ carbocyclisation reaction sequence reported by 
Zhang.39 
Intramolecular Diels-Alder reaction 
Shenvi (Scheme 4) described the total synthesis of racemic amphilectene, a marine 
nanomolar antimalarial agent.40 Intermolecular cycloaddition reaction between dendralene 
25 and dienophile 26 at ambient temperature, followed by the addition of 5 mol% Yb(OTf)3 
afforded an intermediate cross-conjugated enone 27. After heating in o-dichlorobenzene this 
compound underwent a second Diels-Alder cycloaddition reaction in a microwave to produce 
28 in 56% yield with high selectivity (d.r. >10 : 1). Compound 28 was used as a building block 
for the synthesis of racemic amphilectene 29 (Scheme 4). 
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Scheme 4. Intermolecular Diels-Alder/ carbocyclisation reaction sequence reported by 
Shenvi. 40 
8.4.2 Nucleophilic and anionic cyclization for the synthesis of decalin system. 
The total synthesis of myceliothermophin E 6, a potent cytotoxic polyketide, was 
accomplished via a cascade reaction affording the trans-fused decalin ring 31.41 
 
Scheme 5. Nicolaou’s total synthesis of myceliothermophins (6) 
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During this cascade biscyclisation reaction, enolization and intramolecular Michael addition 
was followed by aldol condensation to afford compound 31 in 92% yield (dr = 3 : 1), in the 
presence of catalytic amounts of PTSA in refluxing benzene. This enone decalin system 31 was 
subjected to further reactions to, generate aldehyde intermediate 32 in 15 steps. The final 




















































Figure 3.  Transition states for different stereochemical configurations of 31. 
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Transition state (a) could be used to explain the resultant stereochemistry. As shown in Figure 
3, transition state (b) with steric interaction between H5 and the methyl group at C10, is 
unfavourable in comparison to transition state (a). Major diastereomer transition state (a) in 
which the HOMO of the enolate and the LUMO of the enone are aligned for favourable 
overlap as compared transition state of minor diastereomer (b). Also, the bulkier carbonyl 
group are axial at C10 in transition states (c) and (d), which is unfavourable in comparison to 
transition state (a). The cascade bis-(cyclisation) of the ketoaldehyde afforded decalin 31 in 
excellent yield and good diastereoselectivity in the presence of catalytic amounts of PTSA in 
benzene. 
Allylation reactions  
Intramolecular allylation reactions are examples of nucleophilic cyclisation reactions and have 
been used in the synthesis of 6’-hydroxyarenarol, the proposed precursor of natural product 
popolohuanone E 742 (Scheme 6). Iodide 34 and vinyl bromide 33 were coupled, and the ketal 
was deprotected, to yield the precursor to the Hosomi-Sakurai reaction. Treatment of 35 with 
titanium tetrachloride in the presence of MeSCH2Cl afforded the desired decalin 36 in 68% 
yield as a single diastereomer. The anti-addition of nucleophiles and electrophiles to an enone 
is well known.  
In addition, the formation of a single diastereomer 36 could be explained by dual stereo-
regulation, in terms of orientation and folding-strain stereocontrol (Figure 4). Based on the 
stereocontrol, antiperiplanar transition state (A) should be favoured over the synclinal 
transition state (B) if a chair-like conformation is to be assumed. The folding-strain 
stereocontrol is related to the diastereofacial selection with regard to the C-8 position. In the 
two possible diastereomeric foldings in the transition states A and C, transition state (A) with 
a pseudo-equatorial methyl group, is more stable than transition state (C), which shows 1,3-
allylic repulsion and Gauche interaction.  
 
 




































































Figure 4. Transition states to explain stereochemistry of 36. 
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8.4.3. Decalin ring synthesis by the reaction of alkene/alkyne with an 
electrophilic reagent. 
In Scheme 7, a highly diastereoselective, cationic 6-endo-trig cyclization of 2-alkenyl-1,3-
dithiolane 37 formed trans-decalin compound 38, as reported by Baati.43,44 Furthermore, this 
decalin compound was used in the synthesis of the natural product, triptolide (39). 
 
 
Scheme 7. Baati’s total synthesis of racemic triptolide (39). 
 
In Scheme 8, the plausible reaction mechanism includes the initiation of the reaction by 
interaction of one sulfur atom of 37 with the electrophilic silicon reagent. Thereafter, the 1,3-
dithiolane moiety can temporarily undergo ring opening.45 This affords a highly electrophilic 
cationic intermediate 40, which is stabilized by the mesomeric effect with the conjugated 
vinyl thionium ion 41 and allylic carbenium ion 42. Thioenol 43 is then formed by the 
electrophilic substitution of the aromatic ring and aromatization, followed by the protonation 
of 43 by TfOH to form the sulfonium ion-containing compound 44. Subsequent cyclization, 
regenerates the dithiolane unit, resulting in the formation of compound 38.45 The 
stereochemistry of decalin (+/-) 38 is achieved during the protonation of 43. The steric 
hindrance due to the methyl group blocks the β- face of the molecule; therefore, the proton 
source approaches from the other side (α-face) generating trans-decalin 43.46 
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8.4.4. Radical reactions for decalin ring synthesis. 
Yoshimitsu reported the synthesis of (+/-)-platencin (47) where the key C-C bond formation 
occurred from a radical addition to an alkene; the radical was generated by a titanium(III)-
mediated cyclisation (Scheme 9).47–49 Epoxide 45 underwent homolytic cleavage to generate 
a radical, which then cyclised to afford the cis-decalin ring. Interestingly, both diastereomeric 


























Scheme 9. Yoshimitsu's synthesis of (+/-)-platencin (47). 
The reaction of compound 45 (mixture of diastereomers) under the above reaction conditions 
provided the desired tricyclic compound 46 as a single stereoisomer in 87% yield. This implied 
that both diastereomers of the epoxide generated compound 46, irrespective of their original 
stereochemical configurations. This could be explained by the formation of a single radical by 
the rapid epimerization of the carbon radical centre, which formed the thermodynamically 
stable chair conformation in the transition state, where the bulkier TBS group was locked at 
the equatorial position. This explains the stereoselective cyclisation (Scheme 9). 
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The methods summarised indicate a renewed interest in the syntheses of complex decalin 
ring systems and natural products containing the decalin framework in their molecular 
architecture. Therefore, the isolation of new natural products containing highly functionalised 
and substituted decalin ring systems from various sources and investigation of their biological 
activities have attracted significant attention. The innovation of new methodologies based on 
cyclisation, inter- and intramolecular Diels-Alder, allylation, and radical reactions can provide 
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9. Studies Towards the Synthesis of the Decalin Core of 
Streptosetin A (3).9 
Streptosetin A 3 (Figure 5) is a recently isolated natural product from a marine-derived 
actinomycetes that exhibits human class III HDAC (SIRT) inhibition. Efforts towards the 
synthesis of the decalin core of streptosetin A (3) are currently underway in our research 
laboratory.9 
Sirtins (SIRT) are nicotinamide adenine dinucleotide (NAD)-dependent epigenetic enzymes. 
The mammalian sirtins SIRT1-SIRT7 are involved in numerous cellular functions such as gene 
silencing, and control of the cell cycle and apoptosis.50 In prostate cancer, SIRT1 and SIRT2 are 
overexpressed, and their inhibition affords an anti-proliferative response in human prostate 
cancer cells.51 Streptosetin A (3)9  was obtained from one of the active strains identified 
through a yeast assay and its structure was elucidated by the analysis of 1D and 2D NMR data. 
The stereochemistry was determined by X-ray crystal structure analysis and simulation of ECD 
spectra using time-dependent density functional theory calculations.9 This compound 
showed weak inhibitory activities against yeast Sir2p and human SIRT1 and SIRT2. 
Structurally, streptosetin A (3) is categorized as a polyketide tetramic acid derivative 
produced by the NRPS−PKS hybrid pathway, similar to that reported for equise n isolated 
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9.1 Previous work in the Clarke Group53,54 
9.1.1 Retrosynthetic Analysis via Sakurai Route.  
Prior work within our research group showed that the decalin core of streptosetin A (3) 
lacking the quaternary methyl group could be synthesised successfully via a ring-closing 
metathesis route. 
Streptosetin A (3) would be split into two fragments, the highly functionalised trans-decalin 
core 48 and the tetramic acid 49, in the proposed retrosynthetic strategy (Scheme 10). To 
form the highly functionalised trans-decalin core 50, the key step would be the Sakurai-aldol 
reaction and ring closing metathesis. The Sakurai reaction of allyltrimethylsilane 54 and enone 
52, after enolate trapping by reaction with methacrolein 53 would generate 51. The ring 
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9.1.2 Synthesis of model enone core 59  
Dr. Ian George, a postdoctoral researcher in the Clarke group, developed the synthesis of 
enone 59. Initial work involved the construction of model enone core 59 to determine the 
feasibility of Sakurai and ring-closing metathesis reactions. In a multi-step total synthesis, the 
starting materials should not be expensive, but the cyclohexanones with substitution at the 
4-position are expensive. Thus, the proposed synthesis began with the reduction of compound 
55, followed by the protection of the primary hydroxyl group with TIPS, which afforded a 
diastereomeric mixture of alcohols 56 and 57 in 44% and 14% yields, respectively. This was 
followed by the oxidation of this mixture to a single ketone 58 (99%), and subsequent Ito-
Saegusa oxidation, which converted 58 to enone 59 (Scheme 11).55 
 
Scheme 11. Synthesis of enone 59 by Dr. Ian George. 
Enone 59 was also synthesised by J. Smith, a postgraduate student in our research group 
(Scheme 12). The hydrogenation of the aromatic ring of compound 60 using catalyst PtO2 
generated diols 61/62 as a 1:2 inseparable mixture of stereoisomers in 77% yield.56 Selective 
protection of the primary alcohol of diols 61/62 by treatment with TIPS-Cl generated 
compounds 56/57 in 74% total yield. Oxidation of 56/57 via a Dess-Martin periodinane 
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oxidation generated ketone 58 in 82% yield.57,58 Compound 58 was further converted into the 
corresponding silyl enol ether 63 by treatment with Me3SiCl, sodium iodide, and triethylamine 
in acetonitrile with 92% yield. Then, the Saegusa oxidation of 63 by treatment with Pd(OAc)2 
in DMSO generated enone 59 in 88% yield. 
 
Scheme 12. Synthesis of enone 59 by J.Smith  
9.1.3 Sakurai, aldol, and ring closing metathesis route to decalin ring formation 
J. Smith showed that the decalin core of streptosetin A (3) could be synthesised successfully 
using a ring-closing metathesis reaction. Cyclohexenone, as a model substrate, was subjected 
to the TiCl4-mediated addition of allyltrimethylsilane to form the intermediate titanium 
enolate. This enolate was trapped with methacrolein 53, yielding the aldol products 65 and 
66 in 1:3 diastereomeric ratio (Scheme 13). 
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Scheme 13. Sakurai and Aldol reaction to form 65 and 66. 
The decalin ring was formed via a ring-closing metathesis reaction.  Compounds 65 and 66 
were treated with 5 mol% Grubbs 2nd generation catalyst, resulting in the corresponding 
decalinones 67 and 68 in 67% and 95% yields, respectively (Scheme 14). 
 
Scheme 14. Ring closing metathesis route to decalin ring formation. 
Thus, by employing the routes proposed by J. Smith and Dr. Ian George, who utilized Sakurai, 
aldol, ring-closing metathesis, and Diels-Alder reactions with enone core 59, a versatile 
strategy to build the decalin core streptosetin A 3 can be proposed. These strategies will be 
discussed in detail in the next chapter.  
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10. Results and Discussion 
10.1 Aim and objectives  
The aim of the project was to develop a route for the synthesis of the decalin core of 
streptosetin A 3. The proposed routes to the trans-decalin core are summarised in Scheme 
15. Route 1 would follow a Sakurai and metathesis approach whereas route 2 would explore 
a Diels-Alder approach. The proposed synthesis of the key enone core 52 of the decalin ring 
system follows the same route as that published by Rawal et al. for the synthesis of racemic 
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10.2 Synthetic efforts towards the trans-decalin ring system using Diels-
Alder/epimerisation sequence.  
Prior to beginning the synthesis of the core of streptosetin A 3, initial work was focused on 
exploring the trans-decalin ring system, which was performed by G. Lodovici,54b a 
postgraduate student in the research group.  
Using the precedent from G. Lodovici, the cycloaddition of 64 and 69 was performed in the 
presence of Lewis acid, which generated two decalin products 70 and 71 in a 3.5 : 1 crude 
ratio (cis : trans) (Scheme 16).59 Treatment of 70, under the same Diels-Alder reaction 













36% yield 0.5% yield














8% yield 67% yield
Crude dr 1 : 6 (Cis : trans)
69
Mixture 70 + 71 - 45% yield
 
Scheme 16. Diels-Alder/epimerisation sequence to synthesize the trans-decalin system with 
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The treatment of the model trans-decalin 71 in the presence of LDA at ‒78 °C and TESCl 
afforded TES-enol ether 72 in 78% yield,60 which was then oxidised by IBX at 40 °C. The use of 
1.5 eq. of IBX produced the model enone trans-decalin 73 in 82% yield and ketone trans-
decalin 71 in 16% yield.61 (Scheme 17). 
 
Scheme 17. Synthesis of 73 via IBX oxidation. 
The Hosomi‒Sakurai 1,4-addition62 between enone trans-decalin 73 and allyltrimethylsilane 
54 generated a mixture of products; however, only one product could be isolated and 
characterised as 74 in 39% yield. (Scheme 18). 
 
Scheme 18. The Hosomi‒Sakurai approach for the synthesis of 74. 63 
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Figure 6. The single crystal X-ray diffraction data of 74.  
Figure 6 shows the single-crystal X-ray diffraction data of 74 obtained via the Hosomi‒Sakurai 
1,4 addition, affording the relative stereochemistry required for the continuation of the 
synthesis of anthracimycin 4, the synthetic efforts toward which are currently underway in 
our research group.  
Before starting work on the actual compound of streptosetin A core, initial work was focused 
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10.3 Diels-Alder and Sakurai reaction for the synthesis of trans-decalin core of 
Streptosetin A 3. 
10.3.1. Retrosynthetic analysis Diels-Alder Route 
An alternate Diels-Alder route to the construction of the trans-decalin ring system of 





























































Scheme 19. Retrosynthetic analysis of Streptosetin A 3. 
To form the highly-functionalised trans-decalin core 48 of streptosetin A 3, a Diels‒Alder 
reaction between enone 52 and diene 75 was envisioned. The TIPS-protected enone 52 would 
39 | P a g e  
 
be synthesise by the Diels-Alder reaction between Rawal’s diene 77 and dienophile 
methacrolein 53, followed by reduction and TIPS protection of the primary hydroxyl group 
(Scheme 19). 
10.3.2. Literature Overview of Diels-Alder reaction 
For the construction of six-membered functionalised carbocyclic compounds, Diels-Alder 
reactions are the most widely used pericyclic reactions. The efficiency of the Diels-Alder 
reaction has been validated, particularly for complex natural product synthesis.64 To enhance 
its rate of reaction, Lewis acids are often used, which decreases the energy gap between the 
LUMO of the dienophile and HOMO of the diene.65 
Danishefsky developed a sequence of Lewis-acid-catalysed Diels-Alder reactions to form cis- 
decalin, followed by reductive dehalogenation to generate the trans-decalin system.66 They 
described the Lewis-acid-catalysed (MeAlCl2) Diels-Alder reaction between 2-bromocyclohex-
2-enone 80 and diene 81 to afford a cis- fused bicyclic system 82. Thereafter, using AIBN and 
nBu3SnH radical reduction was performed to remove the bromine at the bridgehead carbon 
with inversion of configuration to generate trans-decalin 83 (Scheme 20). A range of examples 




























Scheme 20. Formation of cis-decalin and inversion of configuration from cis-to trans-decalin 
via radical mechanism. 











































Table 1. Inversion of configuration from cis-to trans-decalin using AIBN and nBu3SnH 
Inspired by this approach, a similar strategy, was envisioned for the construction of the 
decalin core, but the synthesis of enone 76 was first required, for which Rawal’s chemistry 
would be employed. Using this Diels-Alder strategy, the formation of functionalised trans-







41 | P a g e  
 
Various studies suggest that the modification of the diene and dienophile can expand the 
synthetic potential of the Diels-Alder reaction.67 The substitution of the lone-pair-containing 
heteroatoms on the diene can increase the reaction rate and improve the regioselectivity in 
cycloaddition reactions.68 In 1997, Rawal employed a heteroatom-substituted siloxydiene for 
the Diels-Alder reaction (Scheme 21).69,70 Rawal reported several cycloadducts of the Diels-
Alder reaction using diene 77, which is also known as Rawal’s diene, and developed a racemic 
and asymmetric version of the cycloaddition reaction, including the synthesis of the desired 
enone 76, which was a potential key intermediate in our synthetic plan.  
 
 
Scheme 21. Diels-Alder reactions of Rawal's diene 77 and the route to 76 and other 
analogues. 
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This study suggested that the diene with lone-pair-containing heteroatom substituents is 
more reactive towards dienophiles and leads to improved regioselectivity in the cycloaddition 
reaction. Rawal’s diene 77 was reacted with N-phenylmaleimide 87 at -78 °C for one hour to 
afford endo-adduct 88 in 96% yield. The Diels-Alder reaction of 77 with diethyl 
acetylenedicarboxylate 89 was performed at 5 °C to yield the aromatised cycloadduct 90. 
Slightly high temperatures were used for methacrolein 53 and methyl methacrylate 85, which 
yielded cyclised products 84 and 86, respectively. The products of these Diels-Alder reactions 
are potentially versatile intermediates. As an example, methacrolein cycloadduct 84 
proceeded to react with aqueous HCl in THF to afford 91 in 96% yield. Meanwhile, cycloadduct 
84 was subjected to reduction with lithium aluminum hydride (LiAlH4) or Wittig olefination 
and the resulting products were hydrolysed to produce alcohol 76 and alkene 92, respectively 
(Scheme 21). Using this chemistry, the synthesis of racemic enone compound 76 was 
proposed (Scheme 22).  
10.3.3. Synthesis of racemic enone core 76.70 
The synthesis of key enone 76 was initiated by preparing Rawal’s diene 77. First, 4-methoxy-
3-buten-2-one (79) was treated with dimethyl amine to obtain the desired precursor 4-
(dimethylamin)-3-butene-2-one (78) in 83% yield. Compound 78 was subjected to 
deprotonation with potassium bis(trimethylsilyl)- amide (KHMDS) and the subsequent 
trapping of the resulting enolate with tert-butyldimethylsilyl chloride (TBSCl) afforded 1-
(dimethylamino)-3-siloxy1,3-butadiene (Rawal’s diene 77) in 91% yield. The Diels-Alder 
cycloaddition was performed with two equivalents of Rawal’s diene 77 and methacrolein 53 
at 0 °C to room temperature in toluene to generate Diels-Alder product 84. Crude compound 
84 was reduced using LiAlH4, to afford crude alcohol 93. In the next step, the removal of the 
OTBS protection group together with the elimination of dimethylamine from crude 
compound 93, was achieved by treatment with 2.5 equivalents of 70% HF in pyridine to obtain 
the desired racemic enone  76 with 20% overall yield in three steps (Scheme 22). 










THF, 0 °C to r.t.
1.05 eq. KHMDS
1.1 eq. TBSCl






















83% yield 91% yield
Crude
Crude 20% overall yieid
(over 3 steps)  
Scheme 22. Synthesis   of racemic enone core 76. 
10.3.4. HPLC conditions for the analysis of enantioselectivity 
Racemic enone 76 is not sufficiently UV-active for direct HPLC analysis. For this reason, a 
chromophore group needed to be added into compound 76, and therefore, 4-nitrobenzoyl 
ester 95 was chosen and formed in 21% yield (Scheme 23).  
 
Scheme 23. Formation of UV active racemic enone 95. 
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HPLC conditions 
The separation of enantiomers was performed using an HPLC system by employing a 
CHIRALPAKTM IC column with IPA : hexane (50:50) as the mobile phase at a flow rate of 1.0 
mL/min at 40 °C, and run time of 60 minutes.  
Figure 7, shows the separation of two enantiomers in the racemic mixture of 95 that are 
indicated by the two peaks observed in the chromatograph.                                                                                         
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In 2018, Carreira reported the total synthesis of (−)-mitrephorone A, which commenced with 
TADDOL 96-catalysed Diels-Alder reaction of Rawal’s diene 77 and methacrolein 53, followed 
by Wittig methenylation and acidic hydrolysis that generated an enantioenriched enone 97 in 
88% ee and 70% overall yield (Scheme 24).71  
 
Scheme 24. Formation of enantioenriched enone 97.71 
In 2004, Rawal reported the asymmetric synthesis of enone 76.72 Initially, a solution of 
TADDOL 96 and methacrolein 53 in toluene at -80 °C was treated with Rawal’s diene 77 for 
two days. The resulting reaction mixture was treated with LiAlH4 at the same temperature, 
and the mixture was then allowed to warm up to room temperature for 1.5 h. The reaction 
was quenched at 0 °C with water and filtered followed by evaporation of the filtrate. The 
resulting oil was dissolved in acetonitrile and treated with HF for 0.5 h at room temperature. 
Finally, the solvent was evaporated, and the volatiles and residue were purified by silica gel 
chromatography (30:70% hexanes: EtOAc) to afford a clear, colourless oil 76 in 83% yield and 
91% ee (Scheme 25).  
Rawal et al. screened several TADDOL catalysts and showed that different percent yields and 
enantiomeric excesses were obtained. They screened three commercially available TADDOL 
catalysts (96, 98, and 99), and the results showed that the yield and enantioselectivity 
afforded by the reaction depended on the structure of the TADDOL catalyst. The phenyl-
substituted TADDOL 98 and 2-naphthyl-substituted TADDOL 99 afforded 30% and 45% yields 
with 31% and 33% ee, respectively. 1-Naphthyl TADDOL 96 showed the best result, with 83% 
yield and excellent enantioselectivity of 91% ee (Table 2).72 
 












96 Ar = 1-naphthyl
98 Ar = phenyl






TBSO i. LiAlH4, Et2O
-78 °C to r.t., 2 h
ii. HF/CH3CN






Scheme 25. Synthesis of enantioenriched enone 76 reported by Rawal.72 
 
 
Table 2. Effect of TADDOL structure on the yield and enantiomeric excess of 76. 
The rigidity of the TADDOL conformation is due to the hydrogen bond formation.  Dienophile 
(methacrolein) 53 forms a complex with TADDOL through a two-point interaction. First, the 
free hydroxyl group of TADDOL forms an intermolecular hydrogen bond with the carbonyl 
group of the dienophile, which lowers the LUMO energy. The second interaction occurs with 
an electron-deficient carbonyl double bond that is stabilized by the interaction with the 
electron-rich 1-naphthyl ring, which selectively shields one face of the dienophile. Thus, the 
model shows that the Si-face of the aldehyde is available to the diene and accurately predicts 
the absolute configuration of the cycloadduct (Figure 8). 










Figure 8. Proposed working model for TADDOL-catalysed Diels-Alder reaction.72 
 
Therefore, this chemistry was applied to the asymmetric synthesis of 76. 
10.3.5. Asymmetric synthesis of enone core 76.72 
 
Scheme 26. Asymmetric synthesis of enone core 76. 
1-Amino-3-siloxybutadiene (Rawal’s diene 77) and methacrolein 53 were stirred in toluene at 
-80 °C for 48 h with 20 mol% of TADDOL 96 as the chiral catalyst to afford cyclised 
enantioselective product 84 as a crude dark yellow viscous oil. The resulting Diels-Alder 
cycloadduct 84 was reduced using 1.5 eq. of lithium aluminium hydride (LiAlH4) to generate 
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compound 93. Desilylation together with the elimination of dimethylamine was achieved 
using 70% HF in pyridine to yield the desired asymmetric enantioenriched enone 76 in 30% 
overall yield in three steps and 79% ee (Scheme 26).  
Our work confirmed Rawal’s observations that the structure of the TADDOL catalyst played a 
key role in improving the yield and enantioselectivity of the Diels-Alder cycloadduct. An 
additional observation regarding the purity of our starting materials in Diels-Alder reactions 
was made as both the crude and Kugelrohr-distilled pure Rawal’s diene 77 were used. Four 
different results were obtained under identical reaction conditions, where the TADDOL was 
varied which are shown in Table 3. 
Using phenyl TADDOL catalyst 98 and crude 77 in the Diels-Alder reaction, compound 76 was 
obtained with 14% ee (Entry 1). However, when 1-naphthyl TADDOL catalyst 96 and crude 77 
were used in the Diels-Alder reaction, the enantiopurity of 76 increased to 50% and 67% ee 
under the same reaction conditions (Entries 2 and, 3). Using freshly prepared pure 77 and 1-
naphthyl TADDOL catalyst 96, 79% ee (Entry 4) was obtained, but this was still lower than that 
reported by Rawal et al. (Table 3). 
 
Figure 9. Structure of α, α, α’, α’-tetraaryl-1,3-dioxolane-4,5-dimethanol (TADDOL) 
 
 
Table 3.  Effect of TADDOL structure on Diels-Alder reaction. 
This shows that when freshly prepared pure Rawal’s diene is used in the Diels-Alder reaction, 
the percent enantiomeric excess increased. When the purities of 77 were 64% and 96%, these 
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afforded 50% and 67% ee, respectively. When freshly prepared 77 was purified by Kugelrohr 
distillation and the Diels-Alder reaction was performed, an enantioenriched enone 76 in 79% 
ee was obtained (Table 3). 
The enantioenriched enone 76 was protected using TIPSCl to generate TIPS-protected 
compound 52 in 87% yield (Scheme 26). Compound 52 was used for the subsequent Diels-
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10.3.6. Determination of the percent enantiomeric excess of enantioenriched 
enone 95. 
Chiral enone 76 prepared via the TADDOL-catalysed Diels-Alder reaction, was reacted with 94 
to afford 95 in 79% ee, based on the HPLC analysis (Scheme 27).  
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10.3.7. The Diels-Alder reaction of enantioenriched enone 52 with Danishefsky’s 
diene 100. 
In the retrosynthetic route (Scheme 19) discussed previously, decalin core 48 is an important 
scaffold in the structure of streptosetin A (3), the synthesis of which was proposed using the 
Diels-Alder strategy. After successful completion of the synthesis of racemic and 
enantioenriched enone 76, Diels-Alder reactions between enone 52 and several dienes were 
investigated. Danishefsky’s diene 100 was used because it was highly reactive and had been 
previously prepared in the group. The Diels-Alder reactions were performed using 
enantiomerically enriched enone 52 with 1.5 equivalents of Danishefsky’s diene 100 in 
toluene under different conditions, but the cyclised Diels-Alder product 101 was not obtained 
in any case (Scheme 28 and Table 4).  
 
Scheme 28. Diels-Alder reaction of enone 52 and Danishefsky’s diene 100. 
Various temperatures and reaction times were examined for the Diels-Alder reaction of 
enone 52 and Danishefsky diene 100 in toluene (Table 4). 








1 1.5 r.t. 48 No product formation 
Both starting materials decomposed 
2 1.5 80 78 No product formation 
Both starting materials decomposed 
3 1.5 Reflux 4 No product formation 
Both starting materials decomposed 
Table 4. Diels-Alder reactions of enone 52 and Danishefsky’sdiene 100 under various 
conditions. 
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We were unable to recover either of the starting materials due to their decomposition as 
confirmed by TLC and 1H NMR spectroscopy; the reaction mixture became dark and tarry. 
This showed that enone 52 and diene 100 were not sufficiently reactive in the absence of a 
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10.3.8. Lewis-acid-catalysed Diels-Alder reaction of enone 52 and Danishefsky’s 
diene 100.  
The Diels-Alder reactions were performed with enantiomerically enriched enone 52 and 
Danishefsky’s diene 100 in the presence of Lewis-acid catalysts (Scheme 29), but no traces of 
cyclised Diels-Alder product 101 were observed (Table 5). 
 
Scheme 29. Diels-Alder reaction of enone 52 and diene 100. 









1 0.2 eq.  
EtAlCl2 
10 r.t. DCM 19 No product formation 
Both starting materials 
decomposed 
2 10 mol%  
Yb(OTf)3 
1.2 r.t. THF 23 No product formation 
Both starting materials 
decomposed 
3 20 mol%  
Yb(OTf)3 
1.2 r.t. DCM 16 No product formation 
Both starting materials 
decomposed 
4 10 mol% 
BF3OEt2 
1.2 r.t. DCM 18 No product formation 
Both starting materials 
decomposed 
 
Table 5. Lewis-acid-catalysed Diels-Alder reactions of enone 52 and Danishefsky diene 100. 
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Three Lewis-acid catalysts, EtAlCl2, Yb(OTf)3, and  BF3OEt2,  were used but the formation of the 
cyclised Diels-Alder product was not observed. This could be because of the steric hindrance 
of enone 52. Unfortunately, both starting materials decomposed as confirmed by TLC and 1H 
NMR spectroscopy; and the reaction mixture became dark and tarry. 
10.3.9. Diels-Alder reaction of enantioenriched enone 52 with isoprene 69. 
Diels-Alder reactions of enantioenriched enone 52 with isoprene 69 (Scheme 30) were also 
performed in the presence of Lewis-acids at different temperatures, but the Diels-Alder 
product 102 was not formed as confirmed by TLC and 1H NMR spectroscopy. In all cases, both 
starting materials could not be isolated (Table 6). As mentioned previously, this may be 
attributed to the steric hindrance of enone 52. The prior work in the group by G. Lodovici,54b 
showed that the decalin core could be synthesised successfully by the reaction of enone 59 
(lacking quaternary methyl group) with isoprene. 
 
Scheme 30. Diels-Alder reaction of enone 52 with diene 69 in presence of Lewis acid at 
various temperatures. 
Entry Lewis acid Equivalents 
of diene 





1 0.25 eq. 
EtAlCl2 
15 Toluene r.t. 19 No product formation 
2 0.25 eq. 
EtAlCl2 
15 Toluene 40 19 No product formation 
3 0.25 eq. 
EtAlCl2 
15 Toluene 0-r.t. 18 No product formation 
4 10 mol% 
Yb(OTf)3 
15 THF r.t. 21 No product formation 
Table 6. Diels-Alder reaction of enone 52 and isoprene 69 at various temperatures. 
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10.3.10. Synthesis of racemic enone ester 105 
Rawal synthesised a racemic ester enone 105 (Scheme 31), which is less sterically hindered 
than enone 52.70 For this reason, ester enone 105 was prepared for further investigation of 
the Diels-Alder reaction. 
Diels-Alder reaction of Rawal’s diene 77 with 1.5 equivalents of methyl methacrylate 103 was 
performed in toluene at 70 °C to prepare the desired crude cycloadduct 104. Desilylation 
together with the elimination of dimethylamine from 104 using 70% HF in pyridine afforded 
the desired racemic enone 105 in 73% yield (Scheme 31). 
 
Scheme 31. Synthesis of racemic enone ester 105. 
10.3.11. Diels-Alder reaction of racemic enone 105 with Danishefsky’s diene 100 
The Diels-Alder reactions of racemic enone 105 and Danishefsky’s diene 100 were performed 
in the presence of Lewis acids (Scheme 32), but no traces of the Diels-Alder cyclised product 
were observed (Table 7). Attempts to recover both starting materials were made, but 
decomposition occurred in all cases, as confirmed by TLC and 1H NMR spectroscopy.    
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Scheme 32. Diels-Alder reaction of enone 105 with diene 100 in the presence of Lewis acid 
catalysts. 
Entry Lewis acid Equivalents of 
Danishefsky’s 
diene 





1 10 mol% 
Yb(OTf)3 
1.2 THF r.t. 43 No product formation 
Both starting 
materials decomposed 
2 10 mol% 
BF3OEt2 
1.2 DCM r.t. 24 No product formation 
Both starting 
materials decomposed 




Table 7. Diels-Alder reaction of enone 105 with diene 100. 
10.3.12. The Diels-Alder reaction of racemic enone 105 with isoprene 69 
The Diels-Alder reaction of racemic enone 105 and isoprene 69 was performed in the 
presence of Lewis acids, but the Diels-Alder product was still not observed (Scheme 33). Both 
starting materials could not be recovered due to their decomposition, as confirmed by TLC 
and 1H NMR spectroscopy. 
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Scheme 33. Diels-Alder reaction of enone 105 with diene 69 in the presence of Lewis acid 
catalyst. 
Entry Lewis acid Equivalents 
of diene 





1 0.25 eq. 
EtAlCl2 
15 Toluene r.t. 19 No product formation 
Both starting materials 
decomposed 
2 2 eq. ZnCl2 15 Ether 0 
r.t. 
1 No product formation 
Both starting materials 
decomposed 
 
Table 8. Diels-Alder reactions of enone 105 and isoprene 69 in the presence of Lewis acid 
catalysts. 
Several Diels-Alder reactions between enones 52 and 105 and dienes 69 and 100, were 
attempted but the decalin scaffold could not be synthesised. Therefore, an alternate strategy 
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10.3.13. Sakurai approach for the synthesis of streptosetin A core 48  
Owing to the failure of the strategy employing the Diels-Alder reaction, the Sakurai route was 
investigated. The Hosomi-Sakurai 1,4-addition reaction was performed using racemic ester 
enone 105 and allyltrimethylsilane 54 to generate 108 in 35% yield (Scheme 34).  
 
Scheme 34. Sakurai reaction of enone core 108. 
The stereochemistry of 108 was determined via saponification of the ester to its 
corresponding carboxylic acid 109 in 71% yield using aq. lithium hydroxide in THF, followed 
by iodocyclisation24 in the presence of I2 and NaHCO3 to afford bicyclic product 110 in 79% 
yield (Scheme 35). 
 
Scheme 35. Iodocyclisation reaction sequence to determine the stereochemistry of enone 
core 108. 
Compound 110 was heated with 2,4-dinitrophenylhydrazine in methanol to produce 
hydrazone 111 in 75% yield (Scheme 36). The single-crystal X-ray diffraction data of 111 
showed a syn-relationship between methyl C-7 and H-5, and the iodomethyl group was 
oriented in the downward direction opposite to C-7 and H-5. Unfortunately, this did not, 
correspond to the desired configuration of the natural product (Figure 5). 
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Scheme 36. Hydrazone formation to determine the stereochemistry of 111. 
 
 
Figure 11. Single-crystal X-ray diffraction data of 111 showing the syn-relationship between 
C-7 and H-5. 
The asymmetric unit exists in two possible conformers of the bicyclic portion of the molecule 
with E geometry of the hydrazone. The minor form is an enantiomer of the major form with 
the 6-membered rings oriented in boat-like conformations. The racemate crystallised with 
one of each enantiomer in the unit cell.  X-ray crystallography was used to determine the 
stereochemistry, but the data indicated that the desired stereochemical configuration was 
not obtained. However, only one product crystal could be isolated and characterised as 111. 
 
60 | P a g e  
 
10.3.14. Sakurai reaction of enone core 114  
This study was performed because, the Sakurai reaction did not give the stereochemistry 
needed for the natural product target. Sakurai reaction with 114, where the enolate could be 
used to incorporate the methyl group was examined, such that the stereochemistry of 
compound 115 could be determined.  
Treatment of 112 in the presence of LDA at -78 °C and TESCl afforded TES-enol ether 113 in 
53% yield, which was then oxidised using 1.5 equivalents of IBX at 40 °C to produce enone 
114 in 44% yield. Thereafter, the Hosomi-Sakurai 1,4-addition reaction was performed with 




























53% yield 44% yield
 
Scheme 37. Sakurai reaction with enone core 114. 
10.3.15 Sakurai reaction of enone core 76 of streptosetin A  
To determine if the Sakurai reaction could be used to obtain the desired stereochemistry, the 
addition of allylsilane to enone 76 and 52 was investigated.  
The Hosomi-Sakurai 1,4-addition reaction was performed between enone 76 and 
allyltrimethylsilane 54 to generate 116 in 22% yield. A reaction between 116 and 2,4-
dinitrophenylhydrazine in methanol was then performed to generate 117 in 79% yield 
(Scheme 38). However, only one product could be isolated and characterised as 117. 
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Efforts to obtain a crystal of 117 are underway for stereochemical determination by single-
crystal X-ray diffraction. 
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10.3.16. Sakurai reaction strategy for the synthesis of enone core 52 of 
streptosetin A 
The Hosomi-Sakurai 1,4-addition reaction was performed between enone 52 and 
allyltrimethylsilane 54 to afford 118 in 41% yield. Compound 118 was treated with 2,4-
dinitrophenylhydrazine in methanol to generate 119 in 31% yield (Scheme 39). However, only 
one product could be isolated and characterised as 119. Efforts to obtain a crystal of 119 are 
underway for stereochemical determination by single-crystal X-ray diffraction. 
TMS
1.2 eq. TiCl4










0.28 M Acetic acid,










31% yield  






63 | P a g e  
 
11. Conclusion 
The asymmetric synthesis of key enone 76 was achieved in a five-step sequence. The 
enantioenriched enone core 76 was synthesized in 79% ee. Initially, Rawal’s diene 77 was 
prepared, followed by Diels-Alder cycloaddition with methacrolein 53 in the presence of 
TADDOL catalyst to generate cyclised Diels-Alder product 84 (crude). This crude product was 
used in the next step, in which the reduction of the aldehyde group was done to afford crude 
alcohol 93. This crude product was further employed in the next step to remove the OTBS 
protecting group with the elimination of dimethylamine from 93. The reaction was performed 
in 70% HF in pyridine to generate the desired enantioenriched enone compound 76 in 30% 
overall yield over three steps with 79% ee. The enantioenriched enone 76 was protected using 
TIPSCl to generate TIPS-protected compound 52 in 87% yield (Scheme 40). The racemic enone 









THF, 0 °C to r.t.
1.05 eq. KHMDS
1.1 eq. TBSCl

































Scheme 40. Formation of enone core 76. 
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The enone core 76 was protected by the TIPS group to afford compound 52. This compound 
was used for the synthesis of the decalin core under various Diels-Alder reaction conditions 
but the decalin core 50 of the natural product could not be prepared, probably because of 
the steric hindrance in compound 52. Another enone core 105 was prepared via a two-step 
sequence, which also did not afford the desired decalin core 50 (Scheme 41).  
 
Scheme 41. Formation of ester enone core 105. 
An alternative strategy to form the decalin ring of streptosetin A, employing the Sakurai, aldol, 
and ring closing metathesis reactions was explored. The Sakurai 1,4-addition reaction 
between ester enone core 105 and allyltrimethylsilane 54 was performed to afford 35% yield 
of the product. To investigate the stereochemistry, iodocyclised compound 110 and hydrazine 
compound 111 were synthesized, followed by their characterisation using X-ray 
crystallography, but unfortunately, the correct stereochemistry of the product was not 
obtained. Similarly, Sakurai 1,4-addition reaction was attempted with two other enone cores 
76 and 52, and hydrazones 117 and 119, respectively, were further synthesised to determine 
the stereochemistry using single-crystal X-ray crystallography. 
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12. Future work 
The decalin core of Streptosetin A, could be achieved by employing the Sakurai, aldol and ring 
closing metathesis reactions. Initially, would be the Sakurai reaction of enone 52 and 54 then 
it will trap the enolate by aldol reaction. It could generate the compound 120 and 121, further 
the corresponding compounds will subject to metathesis using Hoveyda-Grubbs 2nd 
generation catalyst would then allow the completion to form the compound 50 and 122 
respectively. To determine the stereochemistry of the hydrazone compounds 117 and 119, 
the Sakurai, aldol, and ring closing metathesis reactions will be investigated to study the 
formation of trans-decalin core 50 of Streptosetin A 3 (Scheme 42). 
 
Scheme 42. Sakurai, aldol, and ring closing metathesis reactions for the formation of trans-
decalin core 50 of Streptosetin A 3 
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13. Experimental  
13.1 General experimental 
All non-aqueous reactions were carried out under oxygen-free N2 atmosphere using flame-
dried glassware. Distilled water was used, and brine solution constituted the saturated 
aqueous solution of NaCl. The melting points were measured using a Stuart SMP3 apparatus, 
while the optical rotation data were obtained using a JASCO-DIP370 polarimeter; the [α]D 
values are expressed as 10-1deg.cm2.g-1. The infra-red spectra were recorded using a 
ThermoNicolet Avatar 370 FT-IR spectrometer. NMR spectra were recorded employing Jeol 
ECX-400 and Jeol ECS-400 spectrometers at ambient temperature; chemical shifts are 
expressed in parts per million (ppm) and referenced using the following solvent peaks: CDCl3 
(7.27 ppm), and C6D6 (7.16 ppm) for 1H NMR; CDCl3 (77.0 ppm; central line of the triplet), and  
C6D6 (128.4 ppm; central line of triplet) for 13C NMR. 13C NMR spectra were assigned using the 
DEPT experiments. The coupling constants (J) are quoted in Hertz. Mass spectrometry was 
performed by the University of York mass spectrometry service using electron spray ionisation 
(ESI), electron ionisation (EI), and atmospheric pressure chemical ionisation (APCI) 
techniques.  
All the Mass-spectra data were in a 5-ppm error. Thin layer chromatography was performed 
on glass-backed plates coated with Merck Silica gel 60 F254. The plates were developed using 
ultraviolet light, acidic aqueous ceric ammonium molybdate, basic aqueous potassium 
permanganate. Liquid chromatography was performed using forced flow (flash column) with 
the solvent systems indicated. The stationary phase was silica gel 60 (220–240 mesh) supplied 
by Fluorochem or silica gel Merck TLC grade 11695 supplied by Sigma-Aldrich. Hexane, DCM, 
toluene, THF and Et2O were all purified using Innovative Technology Solvent Purification 
System; diisopropylamine was distilled from calcium hydride. All other solvents and reagents 
were used as received from commercial suppliers. All numbering on the structures below is 
for the benefit of characterisation and does not necessarily conform to the IUPAC rules.  
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13.2 Methods and Characterisation of Compounds 
(5R*, 10S*)-2-Methyl-8,9,10,11,4,5-hexahydronaphthalen-6(2H)-one, 70, 
(5S*, 10S*)-2-Methyl-8,9,10,11,4,5-hexahydronaphthalen-6(2H)-one, 71 
 
To a solution of cyclohexanone 64 (2.0 mL, 20.8 mmol) in dry DCM (104 mL) was added 1.0 M 
solution of EtAlCl2 in hexane (4.16 mL, 4.16 mmol), and the reaction mixture was stirred at 
room temperature for 30 minutes. Isoprene 69 (20.81 mL, 208 mmol) was added, and the 
mixture was stirred at 30 °C for 14 h. Then, 10% aqueous solution of Rochelle’s salt (208 mL) 
was added, and the mixture was further stirred vigorously for one hour. The reaction mixture 
was diluted with water (104 mL) and extracted with DCM (3 × 104 mL). The combined organic 
layers were washed with water (52 mL) followed by brine (52 mL), and then dried using 
Na2SO4, filtered, and concentrated in vacuo. The crude product was purified by silica gel 
column chromatography (2-5% EtOAc in hexane) to yield 70 (1.21 g, 36%) and 71 (17 mg, 
0.5%) as pale-yellow oils, as well as a mixture of 70 and 71 (1.55 g, 45%). The crude product 
contained a 3.5:1 ratio of 70 and 71 by 1H NMR spectroscopy. (5R*, 10S*)-2-methyl-
8,9,10,11,4,5-hexahydronaphthalen-6(2H)-one, 70 Rf =0.42(EtOAc : hexane 5% : 95%). IR 
(ATR): νmax 2928, 1708 (C=O), 1445, 1370, 1310, 1152, 1065, 825, 762 cm-1. 1H NMR (400 MHz, 
CDCl3): δ 5.32 - 5.37 (1 H, m, H-3) 2.64 - 2.70 (1 H, m) 2.42 - 2.45 (1 H, m) 2.35 - 2.41 (2 H, m) 
2.24 - 2.33 (1 H, m) 1.94 - 2.04 (3 H, m) 1.85 (3 H, td, J=8.77, 3.05 Hz) 1.74 - 1.79 (1 H, m) 1.63 
(3 H, s, H-1) ppm. 13C NMR (400 MHz, CDCl3) δ 213.0, 131.8, 118.1, 47.9, 39.9, 36.2, 32.0, 28.4, 
24.0, 23.9, 23.7 ppm. MS (ESI): m/z 187 (M+Na+); HRMS: found: (M+Na+) 187.1098. C11H16NaO 
requires (M+Na+) 187.1093. (5R*, 10S*)-2-methyl-8,9,10,11,4,5-hexahydronaphthalen-6(2H)-
one, 71 trans decalin. Rf = 0.48 (EtOAc : hexane 5% : 95%). IR (ATR): νmax 2915, 1707 (C=O), 
1441, 1376, 1309, 1179, 1149, 1060, 824, 768, 668 cm-1. 1H NMR (400 MHz, CDCl3): δ 5.40 (1 
H, br. s. H-3) 2.31 - 2.49 (2 H, m) 2.13 - 2.20 (2 H, m) 2.01 - 2.13 (3 H, m) 1.87 - 1.97 (2 H, m) 
1.68 - 1.77 (2 H, m) 1.65 (3 H, s, H-1) 1.40 - 1.52 (1 H, m) ppm. 13C NMR (400 MHz, CDCl3) δ 
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212.4, 132.3, 119.9, 50.2, 42.0, 40.4, 38.3, 32.6, 26.1, 24.6, 23.2. MS (ESI): m/z 187 (M+Na+); 
HRMS: found: (M+Na+) 187.1096. C11H16NaO requires (M+Na+) 187.1093. Spectroscopic data 
are consistent with those reported in the literature.59 
Epimerization Method 
To a solution of cis-decalin 70 (1.55 g, 9.47 mmol) in dry DCM (47 mL) was added 1.0 M 
solution of EtAlCl2 in hexane (1.89 mL, 1.89 mmol), and the reaction mixture was stirred for 
16 h. Then, 10% aqueous solution of Rochelle’s salt (162 mL) was added, and the mixture was 
stirred vigorously for one hour. The mixture was diluted with water (81 mL) and the organic 
phase was extracted with DCM (3 × 81 mL). The combined organic layers were washed with 
water (40 mL) followed by brine (40 mL), and then dried using Na2SO4, filtered, and 
concentrated in vacuo. The crude product was purified by silica gel flash column 
chromatography (2-5% EtOAc in hexane) to yield 71 as a pale-yellow oil (989 mg, 67%). 71 
trans- decalin; Rf = 0.48 (EtOAc : hexane 5% : 95%). IR (ATR): νmax 2915, 1707 (C=O), 1441, 
1376, 1309, 1179, 1149, 1060, 824, 768, 668 cm-1.1H NMR (400 MHz, CDCl3): δ 5.40 (1 H, br. 
s. H-3) 2.33 - 2.47 (2 H, m) 2.13 - 2.20 (3 H, m) 2.01 - 2.13 (2 H, m) 1.90 - 1.97 (2 H, m) 1.69 - 
1.77 (2 H, m) 1.63 - 1.67 (3 H, m, H-1) 1.40 - 1.53 (1 H, m) ppm. 13C NMR (400 MHz, CDCl3) δ 
212.4, 132.3, 119.9, 50.2, 42.0, 40.4, 38.3, 32.6, 26.1, 24.6, 23.2 ppm. MS (ESI): m/z 187 
(M+Na+); HRMS: found: (M+Na+) 187.1096. C11H16NaO requires (M+Na+) 187.1093. 
Spectroscopic data are consistent with those reported in the literature.59 
Triethyl-(((11S*, 10S*)-2-methyl,8,9,10,11,4,5-hexahydronaphthalen-6-yl)oxy)silane, 72 
 
To a solution of freshly distilled diisopropylamine (0.6 mL, 4.30 mmol) in dry THF (17.5 mL) at 
-78 °C, was added n-BuLi (3 mL, 1.42 M in hexane, 4.26 mmol), and this solution was stirred 
at -78 °C for 30 minutes. A solution of model trans-decalin 71 (588 mg, 3.58 mmol) in dry THF 
(17.5 mL) was added to the LDA solution and stirred at -78 °C for one hour. Then, freshly 
distilled TESCl (0.78 mL, 4.66 mmol) was added, and the reaction mixture was stirred at -78 
69 | P a g e  
 
°C for additional 30 minutes and allowed to warm to room temperature for 30 min. The 
reaction was quenched by adding water (28 mL), following which it was extracted using Et2O 
(235 mL) and the organic layer was dried using Na2SO4, filtered, and concentrated in vacuo. 
The crude product was purified by silica gel flash column chromatography (100% hexane) to 
yield 72 as a pale-yellow oil (784 mg, 78%). Rf = 0.88 (EtOAc : hexane 10% : 90%). IR (ATR): 
νmax 2959, 2918, 2877, 1661, 1442, 1379, 1245, 1195, 1160, 1015, 978, 885, 800, 735, 689 cm-
1. 1H NMR (400 MHz, CDCl3): δ 5.42 (1 H, d, J=6.1 Hz, H-3) 4.78 - 4.83 (1 H, m) 2.33 - 2.43 (1 H, 
m) 2.01 - 2.17 (2 H, m) 1.89 - 2.01 (1 H, m) 1.73 - 1.84 (1 H, m) 1.62 - 1.72 (5 H, m) 1.57 (3 H, 
s) 0.94 - 1.02 (9 H, m) 0.62 - 0.72 (6 H, m) ppm. 13C NMR (400 MHz, CDCl3) δ 152.6, 133.8, 
121.9, 102.8, 41.1, 38.0, 37.4, 29.2, 29.2, 23.7, 23.4, 6.8, 5.0 ppm. MS (ESI): m/z 279 (M+H+); 
HRMS: found: (M+H+) 279.2126. C17H31OSi requires (M+H+) 279.2138. Spectroscopic data are 
consistent with those reported in the literature.60 
(5S*, 10S*)-2-Methyl-10,11,4,5-tetrahydronaphthalen-6(4H)-one, 73 
 
To a solution of TES-enol trans-decalin 72 (0.784 g, 2.81 mmol) in dry DMSO (23.4 mL), IBX 
(1.97 g, 7.03 mmol) was added, and the reaction mixture was stirred at 40 °C for 24 h. Then, 
the reaction mixture was cooled to room temperature and quenched with a saturated 
aqueous solution of NaHCO3 (150 mL), and reaction mixture was extracted with MTBE (3 × 
200 mL). The combined organic layers were washed with brine (150 mL), dried with Na2SO4, 
filtered, and concentrated in vacuo. The crude product was purified by silica gel flash column 
chromatography (5-10% EtOAc in hexane) to yield 73 as an orange oil (379 mg, 82%). Rf = 0.39 
(EtOAc : hexane 10% : 90%). IR (ATR): νmax 2921, 2849, 1976, 1685 (C=O), 1462, 1375, 1259, 
1115, 1018, 792 cm-1.1H NMR (400 MHz, CDCl3): δ (1 H, ddd, J=9.92, 6.10, 1.53 Hz, H-8) 6.04 
(1 H, dd, J=9.92, 2.29 Hz, H-7) 5.44 (1 H, d, J=2.29 Hz, H-3) 2.46 - 2.58 (2 H, m) 1.97 - 2.23 (6 
H, m) 1.64 - 1.73 (3 H, m, H-1)ppm.  MS (ESI): m/z 163 (M+H+); HRMS: found: (M+H+) 163.1121. 
C11H15O requires (M+H+) 163.1117. Spectroscopic data are consistent with those reported in 
the literature.61 
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(8S*, 5S*, 10R*)-8-Allyl-2-methyl-8,9,10,11,4,5-hexahydronaphthalen-13(2H)-one,74. 
 
To a solution of enone trans-decalin 73 (240 mg, 1.48 mmol) in dry DCM (14.81 mL) at -78 °C 
was added TiCl4 (0.19 mL, 1.7 mmol). After five minutes, allyltrimethylsilane 54 (0.27 mL, 1.70 
mmol) was added and the reaction mixture was stirred at -78 °C for one hour. Thereafter, the 
saturated aqueous solution of NaHCO3 (18.48 mL) was added at -78 °C, stirred for 45 minutes 
and then allowed to warm to room temperature for 30 minutes. The aqueous phase was then 
extracted with DCM (3 × 55 mL), and the combined organic layers were washed with water 
(55 mL) and brine (55 mL), dried with Na2SO4, filtered, and concentrated in vacuo. The crude 
product was purified by silica gel flash column chromatography (1% EtOAc in hexanes) to yield 
74 as a white coloured solid (116 mg, 39%). Rf = 0.27 (EtOAc : hexane 10% : 90%). IR (ATR): 
νmax 2910, 2846, 1708 (C=O), 1640, 1440, 1379, 1352, 1150, 1070, 994, 912, cm-1. 1H NMR 
(400 MHz, CDCl3) δ 5.72 (1H, ddt, J=16.8, J=10.4, J=6.9 Hz, H-13), 5.40 (1H, br. s., H-3), 4.97 - 
5.09 (2 H, m, H-14), 2.58 -2.63 (2 H, m, H-7), 2.36 – 2.41 (1 H, m, H-8), 2.26 - 2.34 (1 H, m, H-
10), 1.95 - 2.08 (3 H, m, H-9 + H-10), 1.83 - 1.94 (3 H, m, H-4 + H-11), 1.59 - 1.71 (4H, m, H-1) 
ppm. 13C NMR (400 MHz, CDCl3) δ 211.9 (C-6), 136.1 (C-13), 132.4 (C-2), 119.7 (C-3), 116.5 (C-
14), 50.2 (C-10), 45.9 (C-7), 38.3 (C-4), 36.9 (C-12), 35.6 (C-5), 35.6 (C-11), 34.8 (C-8), 24.3 (C-
9), 23.1 (C-1). MS (ESI): m/z 227 (M+Na+); HRMS: found: (M+Na+) 227.1407. C14H20NaO 
requires (M+Na+) 227.1406. m/z 205 (M+H+); HRMS: found: (M+H+) 205.1586. C14H21O 
















To a 2.0 M solution of dimethylamine in THF (29.97 mL, 59.93 mmol) was added trans-4-
methoxy-3-buten-2-one 79 (5.0 g, 59.94 mmol) at 0 °C over a period of 30 minutes. The light 
yellow solution was allowed to attain room temperature. After concentrating in vacuo, the 
crude product was purified via bulb to bulb distillation (Kugelrohr distillation at 114 °C and 3 
mm Hg) to yield 78 as a light -yellow oil (3.43 g, 83% yield). Rf = 0.15 (MeOH: DCM 2% : 98%). 
IR (ATR): νmax 1654 (C=O), 1555, 1433, 1349, 1255, 1227, 1107, 949, cm-1. 1H NMR (400 MHz, 
CDCl3) δ 7.42 (1 H, d, J=13.0 Hz, H-4), 5.00 (1 H, d, J=13.0 Hz, H-3), 2.64 - 3.13 (6 H, m, H–5, H-
6) 2.00 - 2.11 (3 H, m, H-1) ppm. 13C NMR (400 MHz, CDCl3) δ 195.1 (C-2), 152.5 (C-4), 96.5 (C-
3), 44.7 (C-5), 36.8 (C-6), 27.8 (C-1). MS (ESI): m/z 136 (M+Na+); HRMS: found: (M+Na+) 
136.0729. C6H11NNaO requires (M+Na+) 136.0733. m/z 114 (M+H+); HRMS: found: (M+H+) 
114.0908. C6H12NO requires (M+H+) 114.0913. Spectroscopic data are consistent with those 















To a solution of KHMDS in toluene (0.5 M, 38.4 mL, 19.2 mmol) was added dry THF (35 mL) 
and it was cooled down to -78 °C. In this solution, dimethylamino-3-buten-2-one 78 (2.07 g, 
18.3 mmol) in dry THF (17 mL) was added over a period of 30 minutes and the reaction was 
then warmed to -30 °C in three hours. Thereafter, the reaction mixture was cooled to -78 °C 
and tert-butyldimethylchlorosilane (3.03 g, 20.1 mmol) in dry THF (15 mL) was further added. 
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The reaction mixture was allowed to attain room temperature overnight. Finally, the reaction 
mixture was diluted with diethyl ether (350 mL), filtered through dry Celite, and concentrated 
in vacuo to afford a crude dark orange viscous oil, which was then purified by bulb to bulb 
distillation (Kugelrohr distillation at 114 °C and 3 mm Hg) to yield 77 as a light yellow oil (3.82 
g, 91%). IR (ATR): νmax 3371, 2928, 1626, 1556, 1419, 1358, 1258, 1231, 1112, 833, 771 cm-1. 
1H NMR (400 MHz, CDCl3) δ 6.58 (1 H, d, J=13.0 Hz, H-6) 4.80 (1 H, d, J=13.0 Hz, H-5) 3.93 (1 
H, s, H-4) 3.84 (1 H, s, H-4) 2.71 (6 H, s, H-7, H-8) 0.96 - 1.00 (9 H, m, H-1) 0.17 - 0.22 (6 H, m, 
H-2) ppm. 13C NMR (400 MHz, CDCl3) δ 156.4 (C-3), 140.9 (C-6), 95.9 (C-5), 85.8 (C-4), 40.5 (C-
7), 25.9 (C-8), 18.3 (C-1), -4.5(C-2) ppm. MS (ESI): m/z 228 (M+H+); HRMS: found: (M+H+) 
228.1776. C12H26NOSi requires (M+H+) 228.1778. Spectroscopic data are consistent with 




Racemic 84: To a solution of Rawal’s diene 77 (200 mg, 0.87 mmol) in dry toluene (0.54 mL) 
was added methacrolein 53 (43.1 mg, 0.61 mmol) at 0 °C. The reaction mixture was stirred 
for one hour at 0 °C and then for three hours at room temperature. It was then concentrated 
in vacuo. The crude mass balance of Diels-Alder cycloadduct 84 was 202 mg. Rf = 0.2 (MeOH 
: DCM 5% : 95%). 
Asymmetric 84: To a solution of methacrolein 53 (326.5 mg, 4.65 mmol) in dry toluene (6.9 
mL) was added 1-napthyl TADDOL (R,R) (96; 621 mg, 0.93 mmol) under N2 atmosphere. The 
reaction mixture was cooled to -80 °C and Rawal’s diene 77 (2.1 g, 9.31 mmol) was added. 
The reaction was stirred at -80 °C for two days and, concentrated in vacuo. The crude mass 
balance of Diels-Alder cycloadduct 84 was 3.37 g. Rf = 0.2 (MeOH : DCM 5% : 95%).  
 





Racemic 93: To a suspension of LiAlH4 (16.4 mg, 0.43 mmol) in dry diethyl ether (1.66 mL) was 
added the solution of the racemic crude 84 (99 mg) in dry diethyl ether (0.87 mL) at -78 °C 
under N2 atmosphere. The reaction mixture was stirred at -78 °C for three hours and diluted 
by adding diethyl ether (4.3 mL). The reaction was quenched with water (0.13 mL) at -78 °C 
under N2 atmosphere. The resulting mixture was allowed to attain the room temperature, 
following which Na2SO4 was added and it was stirred for additional 15 minutes. The organic 
layer and solid were extracted using diethyl ether (3 × 8.45 mL). The organic layer was dried 
using Na2SO4, filtered, and concentrated in vacuo. The crude mass balance of compound 93 
was 91 mg. Rf = 0.1 (MeOH : DCM 5% : 95%). 
Asymmetric 93: To a suspension of LiAlH4 (510 mg, 13.44 mmol) in dry diethyl ether (33.6 mL) 
was added the solution of crude compound 84 (2.0 g) in dry diethyl ether (17.0 mL) at -78 °C 
under N2 atmosphere. The reaction mixture was stirred at -78 °C for three hours and diluted 
by adding diethyl ether (91 mL). The reaction was quenched with water (4.5 mL) at -78 °C 
under N2 atmosphere. The resulting mixture was allowed to attain room temperature, 
following which Na2SO4 was added, and it was stirred for additional 15 minutes. The organic 
layer and solid were extracted using diethyl ether (3 × 50 mL). The organic layer was dried 
using Na2SO4, filtered and concentrated in vacuo. The crude mass balance of compound 93 
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 (R)-4-(Hydroxymethyl)-4-methylcyclohex-2-en-1-one, 76. 
 
Racemic 76: To a solution of crude compound 93 (46.7 mg) in acetonitrile (0.25 mL) was added 
70% HF in pyridine (4.9 μL, 0.39 mmol) under N2 atmosphere at room temperature. The 
reaction mixture was stirred at room temperature for two hours. Thereafter, the reaction was 
quenched by adding a saturated aqueous solution of NaHCO3 (20 mL) and the organic phase 
was extracted with diethyl ether (3 × 20 mL). The combined organic layers were washed with 
a saturated aqueous solution of NaHCO3 (20 mL) and concentrated in vacuo. The crude 
product was purified by silica gel flash column chromatography (100% DCM) to yield 76 as a 
colourless oil (4.4 mg, 20% overall yield over three steps) Rf = 0.31 (MeOH : DCM 10% : 90%). 
Asymmetric 76: To a solution of crude compound 93 (1.0 g) in acetonitrile (3.2 mL) was added 
70% HF in pyridine (0.09mL, 7.63 mmol) under N2 atmosphere at room temperature. The 
reaction mixture was stirred at room temperature for two hours. Thereafter, the reaction was 
quenched by adding a saturated aqueous solution of NaHCO3 (40 mL) and the organic phase 
was extracted with diethyl ether (3 × 80 mL). The combined organic layers were washed with 
a saturated aqueous solution of NaHCO3 (60 mL) and concentrated in vacuo. The crude 
product was purified by silica gel flash column chromatography (100% DCM) to yield 76 as a 
colourless oil (118 mg, 30% overall yield over three steps with 79% ee). Rf = 0.31 (MeOH : 
DCM 10% : 90%). IR (ATR): νmax 3426 (OH), 2931, 1663 (C=O), 1393, 1048, 805 cm-1. 1H NMR 
(400 MHz, CDCl3) δ 6.75 (1 H, d, J=10.2 Hz, H-3) 5.97 (1 H, d, J=10.2 Hz, H-2) 3.45 - 3.65 (2 H, 
m, H-8) 2.46 - 2.53 (2 H, m, H-6) 2.25 (1 H, br. s) 2.04 - 2.14 (1 H, m, H-5) 1.70 - 1.80 (1 H, m, 
H-5) 1.15 (3 H, s, H-7) ppm. 13C NMR (400 MHz, CDCl3) δ 199.6 (C-1), 156.0 (C-3), 129.0 (C-2), 
69.8 (C-8), 38.1 (C-4), 33.8 (C-6), 30.7 (C-5), 21.7 (C-7) ppm. MS (ESI): m/z 163 (M+Na+); HRMS: 
found: (M+Na+) 163.0726. C8H12NaO2 requires (M+Na+) 163.0730. m/z 141 (M+H+); HRMS: 
found: (M+H+) 141.0898. C8H13O2 requires (M+H+) 141.0837. Optical Rotation: [α]D25.0  +27.7 
(c = 0.05, CHCl3). Literature value is [α]D25.0  +25.0 (c = 0.333, CHCl3).70 A % ee of 76 was 
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determined by CSP-HPLC of the p-nitrobenzoate 95. Spectroscopic data are consistent with 
those reported in the literature.70,72 
14%ee of 76 
Asymmetric 84: To a solution of methacrolein 53 (100 mg, 1.42 mmol) in dry toluene (2.1 mL) 
was added phenyl TADDOL (R,R) (98; 113.1 mg, 0.28 mmol) under N2 atmosphere. The 
reaction mixture was cooled to -80 °C and Rawal’s diene 77 (859 mg, 2.85 mmol) was added. 
The reaction was stirred at -80 °C for two days and, concentrated in vacuo. The crude mass 
balance of Diels-Alder cycloadduct 84 was 1.1 g. Rf = 0.2 (MeOH : DCM 5% : 95%).  
Asymmetric 93: To a suspension of LiAlH4 (70.3 mg, 1.85 mmol) in dry diethyl ether (7.1 mL) 
was added the solution of crude compound 84 (1.1 g) in dry diethyl ether (3.7 mL) at -78 °C 
under N2 atmosphere. The reaction mixture was stirred at -78 °C for three hours and diluted 
by adding diethyl ether (18.1 mL). The reaction was quenched with water (0.85 mL) at -78 °C 
under N2 atmosphere. The resulting mixture was allowed to attain room temperature, 
following which Na2SO4 was added, and it was stirred for additional 15 minutes. The organic 
layer and solid were extracted using diethyl ether (3 × 27 mL). The organic layer was dried 
using Na2SO4, filtered and concentrated in vacuo. The crude mass balance of compound 93 
was 924 mg. Rf = 0.1 (MeOH : DCM 5% : 95%).  
Asymmetric 76: To a solution of crude compound 93 (849 mg) in acetonitrile (3.0 mL) was 
added 70% HF in pyridine (0.07mL, 7.08 mmol) under N2 atmosphere at room temperature. 
The reaction mixture was stirred at room temperature for two hours. Thereafter, the reaction 
was quenched by adding a saturated aqueous solution of NaHCO3 (20 mL) and the organic 
phase was extracted with diethyl ether (3 × 30 mL). The combined organic layers were washed 
with a saturated aqueous solution of NaHCO3 (20 mL) and concentrated in vacuo. The crude 
product was purified by silica gel flash column chromatography (100% DCM) to yield 76 as a 
colourless oil (181.5 mg, 91% overall yield over three steps with 14% ee). Rf = 0.31 (MeOH : 
DCM 10% : 90%) 
50%ee of 76 
Asymmetric 84: To a solution of methacrolein 53 (50 mg, 0.71 mmol) in dry toluene (1.06 mL) 
was added 1-napthyl TADDOL (R,R) (96; 95.1 mg, 0.14 mmol) under N2 atmosphere. The 
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reaction mixture was cooled to -80 °C and Rawal’s diene 77 (324 mg, 1.42 mmol) was added. 
The reaction was stirred at -80 °C for two days and, concentrated in vacuo. The crude mass 
balance of Diels-Alder cycloadduct 84 was 664 mg. Rf = 0.2 (MeOH : DCM 5% : 95%).  
Asymmetric 93: To a suspension of LiAlH4 (54.1 mg, 1.42 mmol) in dry diethyl ether (3.56 mL) 
was added the solution of crude compound 84 (664 mg) in dry diethyl ether (1.87 mL) at -78 
°C under N2 atmosphere. The reaction mixture was stirred at -78 °C for three hours and diluted 
by adding diethyl ether (9.7 mL). The reaction was quenched with water (0.45 mL) at -78 °C 
under N2 atmosphere. The resulting mixture was allowed to attain room temperature, 
following which Na2SO4 was added, and it was stirred for additional 15 minutes. The organic 
layer and solid were extracted using diethyl ether (3 × 15 mL). The organic layer was dried 
using Na2SO4, filtered and concentrated in vacuo. The crude mass balance of compound 93 
was 444 mg. Rf = 0.1 (MeOH : DCM 5% : 95%).  
Asymmetric 76: To a solution of crude compound 93 (444 mg) in acetonitrile (1.56 mL) was 
added 70% HF in pyridine (0.04mL, 3.7 mmol) under N2 atmosphere at room temperature. 
The reaction mixture was stirred at room temperature for two hours. Thereafter, the reaction 
was quenched by adding a saturated aqueous solution of NaHCO3 (10 mL) and the organic 
phase was extracted with diethyl ether (3 × 30 mL). The combined organic layers were washed 
with a saturated aqueous solution of NaHCO3 (30 mL) and concentrated in vacuo. The crude 
product was purified by silica gel flash column chromatography (100% DCM) to yield 76 as a 
colourless oil (43.3 mg, 43% overall yield over three steps with 50% ee). Rf = 0.31 (MeOH : 
DCM 10% : 90%) 
67%ee of 76 
Asymmetric 84: To a solution of methacrolein 53 (50 mg, 0.71 mmol) in dry toluene (1.06 mL) 
was added 1-napthyl TADDOL (R,R) (96; 95.1 mg, 0.14 mmol) under N2 atmosphere. The 
reaction mixture was cooled to -80 °C and Rawal’s diene 77 (324 mg, 1.42 mmol) was added. 
The reaction was stirred at -80 °C for two days and, concentrated in vacuo. The crude mass 
balance of Diels-Alder cycloadduct 84 was 410 mg. Rf = 0.2 (MeOH : DCM 5% : 95%).  
Asymmetric 93: To a suspension of LiAlH4 (54.1 mg, 1.42 mmol) in dry diethyl ether (3.56 mL) 
was added the solution of crude compound 84 (410 mg) in dry diethyl ether (1.87 mL) at -78 
°C under N2 atmosphere. The reaction mixture was stirred at -78 °C for three hours and diluted 
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by adding diethyl ether (9.7 mL). The reaction was quenched with water (0.45 mL) at -78 °C 
under N2 atmosphere. The resulting mixture was allowed to attain room temperature, 
following which Na2SO4 was added, and it was stirred for additional 15 minutes. The organic 
layer and solid were extracted using diethyl ether (3 × 15 mL). The organic layer was dried 
using Na2SO4, filtered and concentrated in vacuo. The crude mass balance of compound 93 
was 348 mg. Rf = 0.1 (MeOH : DCM 5% : 95%).  
Asymmetric 76: To a solution of crude compound 93 (348 mg) in acetonitrile (1.56 mL) was 
added 70% HF in pyridine (0.02mL, 1.78 mmol) under N2 atmosphere at room temperature. 
The reaction mixture was stirred at room temperature for two hours. Thereafter, the reaction 
was quenched by adding a saturated aqueous solution of NaHCO3 (30 mL) and the organic 
phase was extracted with diethyl ether (3 × 50 mL). The combined organic layers were washed 
with a saturated aqueous solution of NaHCO3 (30 mL) and concentrated in vacuo. The crude 
product was purified by silica gel flash column chromatography (100% DCM) to yield 76 as a 

















To a solution of compound 76 (159 mg, 1.13 mmol) in dry DMF (4.5 mL) were added imidazole 
(154 mg, 2.27 mmol) and, triisopropylsilyl chloride (0.29 mL, 1.36 mmol) at 30 °C under N2 
atmosphere, and the reaction mixture was stirred at 30 °C for 16 h. Then, an aqueous solution 
of 2 M HCl (0.4 mL) was added, and the mixture was stirred for additional 15 minutes at room 
temperature. The organic phase was extracted with diethyl ether (3 × 25 mL). The combined 
organic layers were washed with water (10 mL) and brine (10 mL), dried using Na2SO4, filtered, 
and concentrated in vacuo. The crude product was purified by silica gel flash column 
chromatography (100% DCM) to yield 52 as a colourless oil (294 mg, 87% yield). Rf = 0.42 
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(MeOH : DCM 5% : 95%). IR (ATR): νmax  2865, 2947, 1685 (C=O), 1465, 1100, 882, 805, 681 
cm-1. 1H NMR (400 MHz, CDCl3) δ 6.77 (1 H, d, J=10.4 Hz, H-3) 5.95 (1 H, d, J=10.4 Hz, H-2) 3.53 
- 3.63 (2 H, m, H-8) 2.49 (2 H, m, J=8.0, J=5.7 Hz, H-6) 2.09 – 2.06 (1 H, m, H-5) 1.75 - 1.72 (1 
H, m, H-5) 1.16 (3 H, s, H-7) 1.03 - 1.08 (18 H, m, H-10) 0.99 - 1.03 (3 H, m, H-9) ppm. 13C NMR 
(400 MHz, CDCl3) δ 199.5 (C-1), 156.2 (C-3), 128.1 (C-2), 70.1 (C-8), 38.3 (C-4), 33.7 (C-6), 30.7 
(C-5), 21.7 (C-7), 17.6 (C-10), 11.5 (C-9) ppm. MS (ESI): m/z 319 (M+Na+); HRMS: found: 
(M+Na+) 319.2058. C17H32NaO2Si requires (M+Na+) 319.2064. m/z 297 (M+H+); HRMS: found: 
(M+H+) 297.2237. C17H33O2Si requires (M+H+) 297.2244. Optical Rotation: [α]D25.0  -64 (c = 0.5, 
CHCl3). 
















Racemic 95: To a solution of compound 76 (1.74 mg, 0.01 mmol) in pyridine (0.8 mL) was 
added dimethyl aminopyridine (0.04 mg, 0.0003 mmol), followed by 4-nitrobenzoyl chloride 
94 (23 mg, 1.12 mmol) at 0 °C under N2 atmosphere. The reaction mixture was warmed to 
room temperature and stirred for 48 h, following which the reaction was quenched by adding 
diethyl ether (30 mL) and a saturated aqueous CuSO4 solution (5 mL). The reaction mixture 
was stirred for 15 minutes and the layers were separated. The aqueous layer was extracted 
using diethyl ether (30 mL) and the combined organic layers were washed with a saturated 
aqueous CuSO4 solution (2 × 10 mL). The organic layer was washed with a saturated aqueous 
solution of NaHCO3 (10 mL), followed by water (10 mL) and brine (10 mL). The organic layer 
was dried using Na2SO4, filtered, and concentrated in vacuo to afford a colourless oil. The 
crude product was purified by silica gel flash column chromatography (100% DCM) to yield 95 
as a white coloured solid (1.3 mg, 21% yield). Rf = 0.5 (MeOH : DCM 5% : 95%). 
Asymmetric 95: To a solution of compound 76 (16 mg, 0.11 mmol) in pyridine (2 mL) was 
added dimethyl aminopyridine (2.79 mg, 0.02 mmol), followed by 4-nitrobenzoyl chloride 94 
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(212 mg, 1.14 mmol) at 0 °C under N2 atmosphere. The reaction mixture was warmed to room 
temperature and stirred for 48 h, following which the reaction was quenched by adding 
diethyl ether (20 mL) and a saturated aqueous CuSO4 solution (5 mL). The reaction mixture 
was stirred for 15 minutes and the layers were separated. The aqueous layer was extracted 
using diethyl ether (3 × 20 mL) and the combined organic layers were washed with a saturated 
aqueous CuSO4 solution (2 × 5 mL). The organic layer was washed with a saturated aqueous 
solution of NaHCO3 (7 mL), followed by water (7 mL) and brine (7 mL). The organic layer was 
dried using Na2SO4, filtered, and concentrated in vacuo to afford a colourless oil. The crude 
product was purified by silica gel flash column chromatography (100% DCM) to yield 95 as a 
white coloured solid (13.2 mg, 40% yield).  Melting point = 123-125 °C. Rf = 0.5 (MeOH : DCM 
5% : 95%). IR (ATR): νmax 3412, 2976, 1639 (C=O), 1484, 1383, 1325, 1163, 1103, 877, 783, 699, 
519 cm-1. 1H NMR (400 MHz, CDCl3) δ ppm 8.29 - 8.34 (2 H, m, H-12) 8.16 - 8.22 (2 H, m, H-11) 
6.77 (1 H, d, J=10.0 Hz, H-3) 6.04 (1 H, d, J=10.0 Hz, H-2) 4.38 (1 H, d, J=11.4 Hz, H-8) 4.26 (1 
H, d=11.4, H-8) 2.53 - 2.60 (2 H, m, H-6) 2.16 - 2.25 (1 H, m, H-5) 1.89 - 1.98 (1 H, m, H-5) 1.32 
(3 H, s, H-7) ppm. 13C NMR (400 MHz, CDCl3) δ 198.1 (C-1), 164.0 (C-9), 153.3 (C-3), 150.3 (C-
13), 134.6 (C-10), 130.3 (C-11), 129.2 (C-2), 123.3 (C-12), 71.1 (C-8), 36.4 (C-4), 33.4 (C-6), 31.0 
(C-5), 22.0 (C-7) ppm. MS (ESI): m/z 312 (M+Na+); HRMS: found: (M+Na+) 312.0842. 
C15H15NNaO5 requires (M+Na+) 312.0842. m/z 290 (M+H+); HRMS: found: (M+H+) 290.1023. 




To a solution of Rawal’s diene 77 (200 mg, 0.87 mmol) in dry toluene (1.0 mL) was added 
methyl methacrylate 103 (0.14 mg, 1.29 mmol) at room temperature. The reaction mixture 
was stirred for 18 h at 70 °C, and then concentrated in vacuo. The crude mass balance of Diels-
Alder cycloadduct 84 was 316 mg. Rf = 0.4 (EtOAc : hexane 30% : 70%). 1H NMR (400 MHz, 
CDCl3) δ  4.85 (1 H, d, J=6.10 Hz) 3.64 - 3.72 (3 H, m) 3.11 (1 H, d, J=5.34 Hz) 2.19 - 2.35 (6 H, 
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m) 1.99 - 2.10 (2 H, m) 1.54 - 1.63 (4 H, m) 1.15 - 1.24 (3 H, m) 0.89 - 0.99 (9 H, m) 0.10 - 0.20 
(6 H, m) ppm. Spectroscopic data are consistent with those reported in the literature.70 
Methyl 1-methyl-4-oxocyclohex-2-enecarboxylate 105 
 
To a solution of crude compound 104 (316 mg) in acetonitrile (0.5 mL) was added 70% HF in 
pyridine (0.03 mL, 1.19 mmol) under N2 atmosphere at room temperature. The reaction 
mixture was stirred at room temperature for 2 h. Then, the reaction was quenched by adding 
saturated aqueous solution of NaHCO3 (25 mL), and the organic phase was extracted using 
diethyl ether (3 × 25 mL). The combined organic layers were washed with a saturated aqueous 
solution of NaHCO3 (20 mL). The organic layer was dried using Na2SO4, filtered, and 
concentrated in vacuo. The crude product was purified by silica gel flash column 
chromatography (30% EtOAc in hexane) to yield 105 as a yellow coloured oil (59.6 mg, 73% 
overall yield over two steps). Rf = 0.47 (EtOAc : Hexane 30% : 70%). IR (ATR): νmax 3000, 1708 
(C=O), 1700, 1519, 1440, 1381, 1314, 1214, 1185, 1009, 742, 668 cm-1. 1H NMR (400 MHz, 
CDCl3) δ 6.87 (1 H, d, J=10.0 Hz, H-5) 5.96 (1 H, d, J=10.0 Hz, H-6) 3.73 (3 H, s, H-9) 2.40 - 2.55 
(3 H, m, H-2, H-3) 1.91 - 2.01 (1 H, m, H-3) 1.43 (3 H, s, H-7) ppm. 13C NMR (400 MHz, CDCl3) 
δ 198.3 (C-1), 174.4 (C-8), 151.5 (C-5), 128.6 (C-6), 52.5 (C-9), 43.7 (C-4), 34.4 (C-2), 32.4 (C-
3), 24.7 (C-7) ppm. MS (ESI): m/z 191 (M+Na+); HRMS: found: (M+Na+) 191.0675. C9H12NaO3 
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To a solution of compound 105 (37.5 mg, 0.22 mmol) in dry DCM (2.23 mL) was added TiCl4 
(0.03 mL, 0.26 mmol) at -78 °C under N2 atmosphere. The resulting mixture was stirred for 5 
minutes at the same temperature and allyltrimethylsilane 54 (0.04 mL, 0.25 mmol) was added 
at -78 °C under N2 atmosphere, following which the resulting solution was further stirred for 
2 h. The reaction was quenched by addition of a saturated aqueous solution of NaHCO3 (3.5 
mL) at -78 °C under N2 atmosphere, and the mixture was allowed to attain room temperature. 
The organic phase was extracted with DCM (3 × 25 mL), and the combined organic layers were 
washed with water (20 mL), followed by brine (20 mL, 5 mL). The organic layer was dried using 
Na2SO4, filtered, and concentrated in vacuo. The crude product was purified by silica gel flash 
column chromatography (10-15% EtOAc in hexane) to yield 108 as a colourless oil (16.6 mg, 
35% yield). Rf = 0.39 (EtOAc: Hexane 30%: 70%). IR (ATR): νmax 3020, 1715, (C=O), 1525, 1398, 
1214, 929, 743, 668 cm-1. 1H NMR (400 MHz, CDCl3) δ 5.59 - 5.73 (1 H, m, H-11) 4.99 - 5.09 (2 
H, m, H-12) 3.74 (3 H,s, H-9) 2.49 - 2.58 (1 H, m, H-2) 2.47 – 2.49 (2 H, m, H-6) 2.25 - 2.41 (2 
H, m, H-2, H-3) 1.93 - 2.07 (1 H, m, H-10) 1.97 - 2.05 (1 H, m, H-10) 1.82 - 1.92 (1 H, m, H-5) 
1.71 - 1.81 (1 H, m, H-3) 1.40 (3 H, s, H-7) ppm. 13C NMR (400 MHz, CDCl3) δ 210.9 (C-1), 175.8 
(C-8), 135.9 (C-11), 117.2 (C-12), 51.7 (C-9), 45.1 (C-5), 44.8 (C-4), 41.9 (C-6), 38.1 (C-2), 35.8 
(C-10), 34.3 (C-3), 23.8 (C-7). MS (ESI): m/z 233 (M+Na+); HRMS: found: (M+Na+) 233.1142. 
C12H18NaO3 requires (M+Na+) 233.1148. m/z 211 (M+H+); HRMS: found: (M+H+) 211.1322. 
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To a solution of compound 108 (16.6 mg, 0.07 mmol) in THF (0.23 mL) was added an aqueous 
solution of LiOH (0.23 mL, 0.23 mmol) at 0 °C. The resulting solution was allowed to attain 
room temperature and stirred for 6 h. The reaction mixture was diluted with diethyl ether (2 
mL) and the pH was adjusted to 1-2 by adding aqueous HCl (1.5 mL, 2 M) at room 
temperature. The resulting solution was extracted with diethyl ether (3 × 15 mL). The organic 
layer was dried using Na2SO4, filtered, and concentrated in vacuo. The crude product was 
purified by silica gel flash column chromatography (1-10% MeOH in DCM) to yield 109 as a 
colourless oil (11.6 mg, 71% yield). Rf = 0.25 (MeOH: DCM 5%: 95%). IR (ATR): νmax 2930, 1705, 
(C=O), 1525, 1110, 1021, 905, 801, 734, 654 cm-1.  1H NMR (400 MHz, CDCl3) δ 5.63 - 5.67 (1 
H, m, H-11) 4.97 - 5.14 (2 H, m, H-12) 2.59 (1 H, br. s.) 2.45 - 2.53 (2 H, m) 2.27 - 2.44 (3 H, m) 
2.02 - 2.12 (1 H, m) 1.86 - 1.98 (1 H, m) 1.73 - 1.84 (1 H, m) 1.40 - 1.51 (3 H, s) ppm. MS (ESI): 
m/z 219 (M+Na+); HRMS: found: (M+Na+) 219.0988. C11H16NaO3 requires (M+Na+) 219.0992. 
m/z 197 (M+H+); HRMS: found: (M+H+) 197.1171. C11H17O3 requires (M+H+) 197.1172. 
















To a solution of compound 109 (10 mg, 0.05 mmol) in acetonitrile (0.5 mL) was added iodine 
(15.5 mg, 0.06 mmol), followed by solid NaHCO3 (8.56 mg 0.10 mmol) at 0 °C under N2 
atmosphere. The reaction mixture was allowed to attain room temperature and stirred for 1 
h. The reaction was then quenched with saturated aqueous solution of Na2CO3 (2 mL) and the 
product was extracted with EtOAc (5 × 20 mL). The combined organic layers were washed 
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with 2 M HCl (aq) (10 mL) followed by brine (10 mL). The organic layer was dried using Na2SO4, 
filtered, and concentrated in vacuo. The crude product was purified by silica gel flash column 
chromatography (0.5-2% MeOH in DCM) to yield 110 as a yellow coloured oil (13 mg, 79% 
yield). Rf = 0.55 (MeOH: DCM 5%: 95%). IR (ATR): νmax 2980, 2252, 1715 (C=O), 1384, 1353, 
1229, 1156, 1098, 1005, 905, 727, 648 cm-1.  1H NMR (400 MHz, CDCl3) δ 4.39 - 4.49 (1 H, m, 
H-9) 3.45 - 3.50 (1 H, m, H-11) 3.39 - 3.44 (1 H, m, H-11) 2.65 - 2.69 (1 H, m, H-6) 2.45 - 2.51 
(1 H, m, H-2) 2.38 - 2.44 (2 H, m, H-2, H-3) 2.30 - 2.36 (2 H, m, H-3, H5) 2.23 - 2.28 (1 H, m, H-
10) 1.85 (1 H, ddd, J=14.3, J=4.6, J=3.1 Hz, H-10) 1.61 - 1.68 (1 H, m, H-6) 1.47 - 1.52 (3 H, m, 
H-7) ppm. 13C NMR (400 MHz, CDCl3) δ 210.2 (C-1), 174.1 (C-8), 75.5 (C-9), 43.8 (C-2), 42.0 (C-
4), 39.9 (C-5), 38.6 (C-6), 35.6 (C-3), 31.0 (C-10), 26.9 (C-7), 9.0 (C-11). MS (ESI): m/z 344 
(M+Na+); HRMS: found: (M+Na+) 344.9946. C11H15INaO3 requires (M+Na+) 344.9958. m/z 323 



























To a solution of compound 110 (7.4 mg, 0.02mmol) in dry methanol (0.65 mL) were added 3 
Å molecular sieves, followed by 2,4-dinitrophenylhydrazine (8.19 mg, 0.04 mmol) at room 
temperature under N2 atmosphere. Then, glacial acetic acid (0.08 mL) was added. The 
resulting solution was heated to 50 °C and stirred at the same temperature for 3 h. The 
reaction was subsequently quenched by adding a saturated aqueous solution of NaHCO3 (1 
mL) and extracted with DCM (3 × 10 mL). The combined organic layers were washed with 
brine (5 mL). The organic layer was dried using Na2SO4, filtered, and concentrated in vacuo. 
The crude product was purified by silica gel flash column chromatography (1% MeOH in DCM) 
to yield 111 as a yellow coloured solid (8.7 mg, 75% yield). Rf = 0.79 (MeOH: DCM 5%: 95%). 
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IR (ATR): νmax 1731 (C=O), 1618, 1518, 1335, 818, 668 cm-1.   1H NMR (400 MHz, CDCl3) δ 11.13 
- 11.26 (1 H, m) 9.11 - 9.14 (1 H, m, H-17) 8.32 (1 H, dd, J=9.7, J=2.7 Hz, H-15) 7.89 - 8.00 (1 H, 
m, H-14) 4.51 (1 H, m) 3.37 - 3.54 (2 H, m) 2.58 - 2.87 (3 H, m) 2.35 - 2.49 (2 H, m) 2.21 - 2.31 
(2 H, m) 2.13 - 2.20 (1 H, m) 1.92 - 2.03 (1 H, m) 1.54 - 1.61 (1 H, m) 1.45 - 1.52 (3 H, m) ppm. 
13C NMR (400 MHz, CDCl3) δ 174.1, 157.6, 145.0, 137.9, 130.0, 123.5, 116.1, 75.3, 53.4, 42.1, 
39.3, 37.4, 34.1, 31.1, 26.3, 24.1, 8.7. MS (ESI): m/z 525 (M+Na+); HRMS: found: (M+Na+) 
525.0238. C17H19IN4NaO6 requires (M+Na+) 525.0242. MP – 168.3 oC. 













To a solution of freshly distilled diisopropylamine (0.99 mL, 7.05 mmol) in dry THF (7.1 mL) at 
-78 °C was added n-BuLi (3.5 mL, 1.98 M in hexane, 6.93 mmol), and this solution was stirred 
at -78 °C for 30 minutes. A solution of ethyl-4-oxycyclohexane carboxylate 112 (0.92 mL, 5.87 
mmol) in dry THF (21.7 mL) was added to the LDA solution and the mixture was stirred at -78 
°C for 1 h. Then, freshly distilled TESCl (1.3 mL, 7.63 mmol) was added and the reaction 
mixture was stirred at the same temperature for additional 30 minutes, after which it was 
allowed to warm to room temperature for 1.5 h. The reaction was quenched by adding water 
(36 mL) and the product was extracted with diethyl ether (400 mL). The organic layer was 
dried using Na2SO4, filtered, and concentrated in vacuo. The crude product was purified by 
silica gel flash column chromatography (100% hexane) to yield 113 as a red coloured oil (896.5 
mg, 53% yield). Rf = 0.68 (EtOAc: Hexane 20%: 80%). IR (ATR): νmax 2894, 1710 (C=O), 1399, 
1274, 987, 908, 776,727, 647 cm-1. 1H NMR (400 MHz, CDCl3) δ 4.85 (1 H, t, J=3.8 Hz, H-4) 4.13 
(2 H, q, J=6.8 Hz, H-10) 2.42 - 2.52 (1 H, m, H-6) 2.23 - 2.31 (2 H, m, H-5) 2.06 - 2.21 (2 H, m, 
H-8) 1.96 - 2.05 (1 H, m, H-7) 1.80 (1 H, m, H-7) 1.21 - 1.29 (3 H, m, H-11) 0.92 - 1.02 (9 H, m, 
H-1) 0.59 - 0.71 (6 H, m, H-2) ppm. 13C NMR (400 MHz, CDCl3) δ 175.5 (C-9), 150.0 (C-3), 101.9 
(C-4), 60.2 (C-10), 39.1 (C-6), 28.8 (C-8), 26.3 (C-5), 25.5 (C-7), 14.1 (C-11), 6.6 (C-1), 4.9 (C-2). 
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MS (ESI): m/z 307 (M+Na+); HRMS: found: (M+Na+) 307.1691. C15H28NaO3Si requires (M+Na+) 
307.1700. m/z 285 (M+H+); HRMS: found: (M+H+) 285.1872. C15H29O3Si requires (M+H+) 
285.1880. 









To a solution of TES-enol compound 113 (844 mg, 2.96 mmol) in dry DMSO (24.7 mL) was 
added IBX (2.0 g, 7.41 mmol) at room temperature, and the reaction was stirred at 40 °C for 
19 h. Then, the reaction mixture was cooled to room temperature, and the reaction was 
quenched by adding a saturated aqueous solution of NaHCO3 (161 mL). The product was 
extracted using MTBE (3 × 250 mL). The combined organic layers were washed with brine (150 
mL), dried using Na2SO4, filtered, and concentrated in vacuo. The crude product was purified 
by silica gel flash column chromatography (20-40% EtOAc in hexane) to yield 114 as an orange 
coloured oil (219.8 mg, 44% yield). Rf = 0.12 (EtOAc: hexane 30%: 70%). IR (ATR): νmax 1730 
(C=O), 1670, 1371, 1251, 1176, 1091, 965, 936, 842, 756 cm-1. 1H NMR (400 MHz, benzene-
d6) δ 6.23 (1 H, d, J=10.0 Hz, H-5) 5.91 (1 H, d, J=10.0 Hz, H-6) 3.67 - 3.83 (2 H, m, H-8) 3.50 (1 
H, s, H-4) 2.32 - 2.49 (2 H, m, H-2) 1.91 - 2.03 (1 H, m, H-3) 1.79 - 1.91 (1 H, m, H-3) 0.74 (3 H, 
t, J=6.8 Hz, H-10) ppm. 13C NMR (400 MHz, benzene-d6) δ 196.6 (C-1), 174.0 (C-7), 146.8 (C-
5), 130.9 (C-6), 71.7 (C-4), 62.5 (C-8), 34.0 (C-2), 30.2 (C-3), 13.8 (C-9). MS (ESI): m/z 207 
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To a solution of compound 76 (29.3 mg, 0.20 mmol) in dry DCM (2.09 mL) was added TiCl4 
(0.03 mL, 0.25 mmol) at -78 °C under N2 atmosphere. The resulting mixture was stirred for 5 
minutes at the same temperature and allyltrimethylsilane 54 (0.04 mL, 0.24 mmol) was added 
at -78 °C under N2 atmosphere, following which the resulting solution was further stirred for 
2.5 h. The reaction was quenched by addition of a saturated aqueous solution of NaHCO3 (3 
mL) at -78 °C under N2 atmosphere, and the mixture was allowed to attain room temperature. 
The organic phase was extracted with DCM (3 × 20 mL), and the combined organic layers were 
washed with water (20 mL), followed by brine (20 mL mL). The organic layer was dried using 
Na2SO4, filtered, and concentrated in vacuo. The crude product was purified by silica gel flash 
column chromatography (2% MeOH in DCM) to yield 116 as a colourless oil (8.3 mg, 22% 
yield). Rf = 0.45 (MeOH: DCM 5%: 95%). IR (ATR): νmax 2973, 1970 (C=O), 1703, 1640, 1423, 
1391, 1244, 1140, 1039, 998, 913 cm-1. 1H NMR (400 MHz, CDCl3) δ 5.59 - 5.78 (1 H, m, H-11) 
4.92 - 5.10 (2 H, m, H-12) 3.70 - 3.79 (1 H, m, H-8) 3.63 (1 H, d, J=10.6 Hz, H-8) 2.32 - 2.51 (4 
H, m) 2.24 (1 H, dd, J=15.2, J=8.3 Hz) 1.94 - 2.10 (1 H, m) 1.74 - 1.85 (2 H, m) 1.49 (1 H, ddd, 
J=13.7, J=10.0, J=5.3 Hz) 1.11 - 1.28 (3 H, m, H-7) ppm. 13C NMR (400 MHz, CDCl3) δ 212.2, 
136.7, 117.1, 66.2, 44.3, 42.2, 37.8, 34.6, 33.3, 23.3, 15.5. MS (ESI): m/z 205 (M+Na+); HRMS: 
found: (M+Na+) 205.1194. C11H18NaO2 requires (M+Na+) 205.1199. m/z 183 (M+H+); HRMS: 
found: (M+H+) 183.1376. C11H19O2 requires (M+H+) 183.1380. 






















To a solution of compound 116 (5 mg, 0.02 mmol) in dry methanol (0.78 mL) was added 3 Å 
molecular sieves, followed by 2,4-dinitrophenylhydrazine (9.7 mg, 0.05 mmol) at room 
temperature under N2 atmosphere. Then, glacial acetic acid (0.1 mL) was added. The resulting 
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solution was heated to 50 °C and stirred at same temperature for 3 h. The reaction was 
subsequently quenched by adding a saturated aqueous solution of NaHCO3 (1 mL) and 
extracted with DCM (3 × 20 mL). The combined organic layers were washed with brine (20 
mL). The organic layer was dried using Na2SO4, filtered, and concentrated in vacuo. The crude 
product was purified by silica gel flash column chromatography (1% Methanol in DCM) to 
yield 117 as a yellow coloured solid (7.8 mg, 79% yield). Rf = 0.59 (MeOH: DCM 5% : 95%). IR 
(ATR): νmax 2921, 1618, 1588, 1525, 1336, 1229, 1033, 907, 733, 651 cm-1. 1H NMR (400 MHz, 
CDCl3) δ 11.19 (1 H, d, J=6.8 Hz) 9.13 (1 H, d, J=2.2 Hz) 8.29 (1 H, dd, J=10.0, 2.2 Hz) 7.96 (1 H, 
dd, J=10.0, 2.1 Hz) 5.66 - 5.86 (1 H, m, H-11) 5.07 - 5.18 (2 H, m, H-12) 3.53 - 3.74 (3 H, m) 2.51 
- 2.69 (3 H, m) 2.29 - 2.50 (3 H, m) 1.94 - 2.07 (2 H, m) 1.78 - 1.93 (1 H, m) 1.26 (3 H, br. s.) 
ppm. MS (ESI): m/z 385 (M+Na+); HRMS: found: (M+Na+) 385.1487. C17H22N4NaO5 requires 
(M+Na+) 385.1482. m/z 363 (M+H+); HRMS: found: (M+H+) 363.1662. C17H23N4O5 requires 
(M+H+) 363.1663. m/z 401 (M+K+); HRMS: found: (M+K+) 401.1229. C17H22KN4O5 requires 
















To a solution of compound 52 (9 mg, 0.03 mmol) in dry DCM (0.3 mL) was added TiCl4 (4 μL, 
0.036 mmol) at -78 °C under N2 atmosphere. The resulting mixture was stirred for 5 minutes 
at the same temperature and allyltrimethylsilane 54 (5.5 μL, 0.035 mmol) was added at -78 
°C under N2 atmosphere, following which the resulting solution was further stirred for 45 
minutes. The reaction was quenched by addition of a saturated aqueous solution of Na2HCO3 
(1.5 mL) at -78 oC under N2 atmosphere, and the mixture was allowed to attain room 
temperature. The organic phase was extracted with DCM (3 × 10 mL), and the combined 
organic layers were washed with water (5 mL), followed by brine (2 × 5 mL). The organic layer 
was dried using Na2SO4, filtered, and concentrated in vacuo. The crude product was purified 
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by silica gel flash column chromatography (5% EtOAc in hexane) to yield 118 as a colourless 
oil (4.2 mg, 41% yield). Rf = 0.32 (EtOAc : hexane 10% : 90%). IR (ATR): νmax 2928, 2868, 1716 
(C=O), 1462, 1253, 1097, 1070, 1000, 917, 809, 683 cm-1. 1H NMR (400 MHz, CDCl3) δ ppm 
5.61 - 5.73 (1 H, m, H-12) 4.98 - 5.07 (2 H, m, H-13) 3.76 (1 H, d, J=10.0 Hz, H-8) 3.63 (1 H, d, 
J=10.0 Hz, H-8) 2.39 - 2.52 (2 H, m, H-6) 2.24 - 2.38 (2 H, m) 1.76 - 1.86 (2 H, m) 1.58 (3 H, s) 
1.46 (2 H, d, J=4.5 Hz) 1.12 - 1.18 (3 H, m) 1.04 - 1.12 (16 H, m) 0.97 - 1.04 (3 H,m) ppm. 13C 
NMR (400 MHz, CDCl3) δ 212.6 (C-1), 136.8 (C-12), 116.8 (C-13), 67.2 (C-8), 43.9 (C-6), 42.0 (C-
2), 37.9 (C-3), 37.5 (C-4),  34.5 (C-11), 33.3 (C-6), 23.7 (C-7), 17.9 (C-10), 11.9 (C-9). MS (ESI): 
m/z 361 (M+Na+); HRMS: found: (M+Na+) 361.2549. C20H38NaO2Si requires (M+Na+) 361.2533. 
m/z 339 (M+H+); HRMS: found: (M+H+) 339.2720. C20H39O2Si requires (M+H+) 339.2714. m/z 


























To a solution of compound 118 (9 mg, 0.02mmol) in dry methanol (0.75 mL) was added 3 Å 
molecular sieves, followed by 2,4-dinitrophenylhydrazine (9.47 mg, 0.04 mmol) at room 
temperature under N2 atmosphere. Then, glacial acetic acid (0.09 mL) was added. The 
resulting solution was heated to 50 °C and stirred at same temperature for 3 h. The reaction 
was subsequently quenched by adding a saturated aqueous solution of NaHCO3 (1 mL) and 
extracted with DCM (3 × 20 mL). The combined organic layers were washed by brine (20 mL). 
The organic layer was dried with Na2SO4, filtered, and concentrated in vacuo. The crude 
product was purified by silica gel flash column chromatography (5% EtOAc in hexane) to yield 
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119 as a yellow coloured solid (4.3 mg, 31% yield). Rf = 0.25 (EtOAc: hexane 10% : 90%). IR 
(ATR): νmax 2942, 2866, 1618, 1593, 1520, 1423, 1332, 1310, 1096, 923, 882, 832, 806, 744, 
684, 655 cm-1. 1H NMR (400 MHz, CDCl3) δ 11.19 (1 H, d, J=8.3 Hz) 9.14 (1 H, d, J=3.0 Hz) 8.29 
(1 H, dd, J=9.5, J=2.6 Hz) 7.89 - 8.03 (1 H, m) 5.66 - 5.83 (1 H, m, H-12) 5.10 (2 H, m, H-13) 3.55 
- 3.79 (2 H, m) 2.33 - 2.64 (5 H, m) 2.05 (1 H, s) 1.36 - 1.49 (1 H, m) 1.22 - 1.32 (3 H, m) 1.04 - 
1.14 (21 H, m) ppm. 13C NMR (400 MHz, CDCl3) δ 161.3, 145.5, 137.5, 130.2, 124.0, 117.8, 
116.4, 68.5, 53.7, 44.3, 38.2, 31.2, 27.6, 24.1, 18.3, 12.2. MS (ESI): m/z 519 (M+H+); HRMS: 

























Å   Ångstrom  
ACP   acyl carrier protein  
AcOH   acetic acid  
APCI   atmospheric pressure chemical ionization  
BF3·Et2O  borane trifluoride-diethyl etherate  
Brsm  based on recovered starting material  
n-BuLi   butyl lithium  
t-BuOH  tert-butanol  
CA   california  
C-C   carbon-carbon  
DCM   dichloromethane  
CHCl3   chloroform  
CH3CN   acetonitrile  
d   day  
D-Ala   D-alanine  
DBU   1,8-diazabicyclo[5.4.0]undec-7-ene  
DIBAL-H  diisobutylaluminum hydride  
DIPEA   N,N-diisopropylethylamine  
DMAP   4-dimethylaminopyridine  
DMF   dimethylformamide  
DMP   Dess-Martin periodinane  
2, 4-DMP 2, 4-dinitrophenylhydazine 
DMPU   1,3-Dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone  
DMSO  dimethylsulfoxide 
DNA  deoxyribonucleic acid 
Dr  diastereomeric ratio 
ESI  electrospray ionisation 
EI  electron ionisation 
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Et2O   diethyl ether  
EtOAc   ethylacetate  
EtOH   ethanol  
Et3N   triethylamine  
FAD   flavin adenine dinucleotide  
FGI   functional group interconversion  
g   gram  
h   hour  
H2   hydrogen  
HCC   hepatocellular carcinoma  
HCl   hydrochloric acid  
HG II   hoveyda-Grubbs 2nd generation catalyst  
Hg   mercury  
HOMO  highest occupied molecular orbital  
HRMS   high resolution mass spectrometry  
Hz   hertz  
I2   iodine  
IBX   2-iodoxy benzoic acid  
IC50   half maximal inhibitory concentration  
IR   infrared spectroscopy  
J   coupling constant (Hz)  
KHMDS  potassium hexamethyldisilazide  
LDA  lithium diisopropylamide 
LED   light emitting diodie  
LiAlH4   lithiumaluminium hydride  
LovBPKS  lovastatin B polyketide synthase  
LUMO   lowest unoccupied molecular orbital  
M   molar  
m-CPBA  meta-chloroperoxybenzoic acid  
Me   methyl  
MeOH   methanol  
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MIC   minimum inhibitory concentration  
Min.   minutes  
Ms   mesyl (methanesulfonyl)  
MsCl   mesylchloride  
mg   milligram  
MHz   megahertz  
MRSA   methicillin resistant bacteria  
MS   mass spectrometry  
M.S.   molecular sieves  
MW   microwaves  
NMR   nuclear magnetic resonance spectroscopy  
NOE   nuclear overhauser effect  
Pd(OAc)2  palladium acetate 
Pd/C   palladium on carbon  
Ph   phenyl  
PhI(OAc)2  diacetoxyiodo benzene  
PKS   polyketide synthase  
PPh3   triphenylphosphine  
PMB   p-methoxybenzyl  
Py   pyridine  
RNA   ribonucleic acid  
rt   room temperature  
SiO2   silica  
TBAF   tetra-n-butylammonium fluoride  
TBS   t-butyldimethylsilyl  
TES   triethylsilyl  
Tf   triflate  
THF   tetrahydrofuran  
TIPS   triisopropylsilyl  
TLC   thin layer chromatography  
TMS   trimethylsilyl  
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TS   transition state  





















94 | P a g e  
 
15.  References 
1. S. Firakova, M. Sturdikova and M. Muckova, Biologia, Bratislava, 2007, 62/3, 251—
257, Section Botany 
2. A. Sharma, N. Kumari, E. Menghani, Int. J. Eng. Res., 2014, 5, 4, 1395 ISSN, 2229-
5518. 
3. K. C. Nicolaou, Proc. R. Soc. A 470: 20130690 
4. J. Hong, Chem. Eur. J. 2014, 20, 10204 – 10212. 
5. G. Li, S. Kusari and M. Spiteller, Nat. Prod. Rep., 2014, 31, 1175–1201. 
6. E. M. Stocking and R. M. Williams, Angew. Chem., Int. Ed., 2003, 42, 3078–3115. 
7. K. Uchida, T. Ogawa, Y. Yasuda, H. Mimura, T. Fujimoto, T. Fukuyama, T. Wakimoto, 
T. Asakawa, Y. Hamashima and T. Kan, Angew. Chem., Int. Ed., 2012, 51, 12850–
12853 
8. V. Singh, S. R. Iyer and S. Pal, Tetrahedron, 2005, 61, 9197–9231. 
9. T. Amagata, J. Xiao, Y. P. Chen, N. Holsopple, A. G. Oliver, T. Gokey, A. B. Guliaev and 
K. Minoura J. Nat. Prod., 2012, 2193−2199. 
10. K.H. Jang, S. J. Nam, J. B. Locke, C. A. Kauffman, D. S. Beatty, L. A.  Paul and W. 
Fenical, Angew. Chem, Int. Ed., 2013, 52, 7822–7824. 
11. S. B. Singh, H. Jayasuriya, J. G. Ondeyka, K. B. Herath, C. Zhang, D. L. Zink, N. N. Tsou, 
R. G. Ball, A. Basilio, O. Genilloud, M. T. Diez, F. Vicente, F. Pelaez, K. Young and J. 
Wang, J. Am. Chem. Soc., 2006, 128, 11916–11920. 
12.  Y. L. Yang, C. P. Lu, M. Y. Chen, K. Y. Chen and Y. C. Wu., Chem. Eur. J., 2007, 13, 
6985 – 6991. 
13.  P. J. Carney and J. R. Scheuer, Tetrahedron Lett., 1993, 34, 3727-3730. 
14. J. Wang, Nature, 2006, 441, 358–361. 
15. F. Schmitz, V. Lakshmi, D. Powell and D. R. van der Helm, J. Org. Chem., 1984, 49, 
241-244. 
95 | P a g e  
 
16. D. J. Carte, B. Rose, and C. B. Faulkner, J. Org. Chem., 1985, 50, 2785. 
17. P. M. Dewick, Medicinal Natural Products: A Biosynthentic Approach, 2nd ed.; John 
Wiley and Son: West Sussex, UK, 2002, 520.  
18. R. A. Maplestone, M. J. Stone and D. H. Williams, The evolutionary role of secondary 
metabolites, A review. Gene 1992, 115, 151–157. 
19. S. M. Colegate, R. J. Molyneux, Bioactive Natural Products: Detection, Isolation and 
Structure Determination; CRC Press: Boca Raton, FL, USA, 2008, 421–437. 
20. D. J. Newman and G. M. Cragg, J. Nat. Prod., 2012, 75, 311–335. 
21. D. A. Dias, S. Urban and U. Roessner, Metabolites, 2012, 2, 303–336. 
22. A. Der Marderosian and J. A. Beutler, The Review of Natural Products, 2nd ed.; Facts 
and Comparisons; Seattle, WA, USA, 2002, 13–43. 
23. K. C. Nicolaou and S. A. Snyder, Angew. Chem., Int. Ed., 2005, 44, 1012–1044. 
24. K. J. Staunton and J. Weissman, Nat. Prod. Rep., 2001, 18, 380–416. 
25. B. Alt and S. Wilkinson, ACS Chem. Biol., 2015, 10, 2668–2679. 
26. P. C. Calderone, C. T. Kowtoniuk, W. E. Kelleher, N. L. Walsh and C. T. Dorrestein, 
Proc. Natl. Acad. Sci, USA 2006, 103, 8977–8982. 
27. T. Bretschneider, J.B. Heim, D. Heine, R. Winkler, B. Busch, B. Kusebauch, T. Stehle, 
G. Zocher, and C. Hertweck, Nature, 2013, 502, 124–128. 
28. C. Zhao, J. M. Coughlin, J. Ju, D. Zhu, E. Wendt-Pienkowski, X. Zhou, Z. Wang, B. Shen, 
and Z. Deng, J. Biol. Chem., 2010, 285, 20097–20108. 
29. T. Hashimoto, J. Hashimoto, K. Teruya, T. Hirano, K. Shin-Ya, H. Ikeda, H. W. Liu, M. 
Nishiyama, and T. Kuzuyama, J. Am. Chem. Soc., 2015, 137, 572–575. 
30. T. Ose, K. Watanabe, T. Mie, M. Honma, H. Watanabe, M. Yao, H. Oikawa, and I. 
Tanaka, Nature, 2003, 422, 185–189. 
31. H. Oikawa, K. Katayama, Y. Suzuki, and A. Ichihara, J. Chem. Soc; Chem. Commun., 
1995, 13, 1321–1322. 
96 | P a g e  
 
32. K. Kasahara, T. Miyamoto, T. Fujimoto, H. Oguri, T. Tokiwano, H. Oikawa, Y. Ebizuka, 
and I. Fujii, ChemBioChem, 2010, 11, 1245–1252. 
33. K. Auclair, A. Sutherland, J. Kennedy, D. J. Witter, J. P. Heever, C. R. Hutchinson and J. 
C. Vederas, J. Am. Chem. Soc., 2000, 122, 11519–11520. 
34. S. M. Ma, J. W. H. Li, J. W. Choi, H. Zhou, K. K. M. Lee, V. A. Moorthie, X.  Xie, J. T. 
Kealey, N. A. Da Silva, J. C. Vederas, and Y. Tang, Science, 2009, 326, 589–592. 
35. H. J. Kim, M.W. Ruszczycky, S.H. Choi, Y.N. Liu and S.H. Liu, Nature, 2011, 473, 109–
112. 
36. Q. Wu, Z. Wu, X. Qu and W. Liu, J. Am. Chem. Soc., 2012, 134, 17342–17345. 
37. C. D. Campbell and J. C.  Vederas, Biopolymers, 2010, 93, 755–763. 
38. S. Dhambri, S. Mohammad, O. N. Van Buu, G. Galvani, Y. Meyer, M. I. Lannou, G. 
Sorin and Ardisson J., Nat. Prod. Rep., 2015, 32, 841–864. 
39. L. Zhu, C. Zhou, W. Yang, S. He, G.J. Cheng and C.S. Lee, J. Org. Chem., 2013, 78, 
7912-7929. 
40. S. V. Pronin and R. A. Shenvi J. Am. Chem. Soc., 2012, 134, 19604–19606. 
41. K. C. Nicolaou, L. Shi, M. Lu, M. R. Pattanayak, A. Shah, M. Ioannidou and H. Lamani 
Angew. Chem., Int. Ed., 2014, 53, 10970-10974. 
42. R. H. Munday, R. M. Denton and J. C. Anderson J. Org. Chem., 2008, 73, 8033-8038. 
43. S. Goncalves, S. Santoro, M. Nicolas, A. Wagner, P. Maillos, F. Himo and R. Baati, J. 
Org. Chem., 2011, 76, 3274-3285. 
44. D. Yang, X. Ye and X. Ming, J. Org. Chem., 2000, 65, 2208-2217. 
45. A. Martel, S. Chewchanwuttiwong, G. Dujardin and E. Brown, Tetrahedron Lett., 
2003, 44, 1491-1494. 
46. S. Goncalves, P. Hellier, M. Nicolas, A. Wagner and R. Baati, Chem. Commun. 2010, 
46, 5778–5800. 
47. M. Saleem, H. Hussain, I. Ahmed,  and K. Krohn, Nat. Prod. Rep., 2011, 28, 1534-
97 | P a g e  
 
1579. 
48. Y. Zou, C. H. Chen, C. D. Taylor, B. M. Foxman and B. B. Snider, Org. Lett., 2007, 9, 
1825-1828. 
49. T. Yoshimitsu, S. Nojima, M. Hashimoto and T. Tanaka, Org. Lett., 2011, 13, 3698-
3701. 
50. H. Yamamoto, K.  Schoonjans and J. Auwerx. J. Mol. Endocrinol., 2007, 21, 
1745−1755. 
51. B. Jung-Hynes, M. Nihal, W. Zhong and N. Ahmad, J. Biol. Chem., 2009, 284, 
3823−3832. 
52. J. W. Sims, J. P. Fillmore, D. D. Warner and E. W. Schmidt, Chem. Commun., 2005, 
186−188. 
53. Dr. Ian George, Postdoctoral researcher in Clarke group, University of York, 
Chemistry Department, UK. 
54. a) Joshua C. Smith, Doctor of Philosophy thesis, University of York, Chemistry 
Department, UK, 2016, b) G. Lodovici, Doctor of Philosophy thesis, University of York, 
Chemistry Department, UK, 2016. 
55. Y. Ito, T. Hirao and T. Saegusa, J. Org. Chem., 1978, 43, 1011–1013. 
56. D. N. a. O. V. K. Marina, Russ. Chem. Rev., 1998, 67, 587-616. 
57. D. B. Dess and J. C. Martin, J. Am. Chem. Soc., 1991, 113, 7277-7287 
58. D. B. Dess and J. C. Martin, J. Org. Chem., 1983, 48, 4155-4156. 
59. C. R. Eklund, L. Axelsson and A. K. Nordahl, Acta Chem. Scand., 1993, 47, 581– 591. 
60. N. A. Da W. Xu, Y. H. Chooi, J. W. Choi, S. Li, J. C. Vederas and Y. Tang, Angew. Chem., 
Int. Ed., 2013, 52, 6472–6475. 
61. K. C. Nicolaou, T. Montagnon and P. S. Baran, J. Am. Chem. Soc., 2002, 124, 2245–
2258. 
62. A. Hosomi, Tetrahedron Lett., 1976, 17, 1295–1298. 
98 | P a g e  
 
63. N. M. H. Kobayashi, R. Sunaga, K. Furihata and S. Iwasaki, J. Antibiot., 1995, 48, 42–
52. 
64. K. C. Nicolaou, S.A.  Snyder, T. Montagnon and G. Vassilikogiannakis, Angew. Chem., 
Int. Ed., 2002, 41, 1668–1698. 
65. H. Wasserman and D. Cohen, J. Chem. Soc., Chem. Comm., 1960, 82, 4436–4437. 
66. J. H. Lee, Y. Zhang and S.J. Danishefsky, J. Am. Chem. Soc., 2010, 132, 14330–14333. 
67. Comprehensive Organic Synthesis; Pergamon Press: New York, 1991, 5, 315-400. 
68. M. Petrzilka and J. I.  Grayson, Synthesis, 1981, 753-786. 
69. S. Danishefsky, Acc. Chem. Res., 1981, 14, 400-406. 
70. S. A. Kozmin and V. H. Rawal, J.Org.Chem., 1997, 62, 5252–5253. 
71. J. R. Matthieu Richter, M. Schneider, M. Brandstatter, S. Krautwald, and E. M. 
Carreira, J. Am. Chem. Soc., 2018, 140, 16704−16710 













99 | P a g e  
 
16.  Appendices 
Appendix A: Crystal data and structure refinement for 74.  
 
Crystal data and structure refinement for 74.  
Identification code  pac1901  
Empirical formula  C14H20O  
Formula weight  204.30  
Temperature/K  110.05(10)  
Crystal system  monoclinic  
Space group  P21/n  
a/Å  7.9841(3)  
b/Å  17.5709(5)  
c/Å  9.2686(3)  
α/°  90  
β/°  114.604(4)  
γ/°  90  
Volume/Å3  1182.22(8)  
Z  4  
ρcalcg/cm3  1.148  
100 | P a g e  
 
μ/mm-1  0.533  
F(000)  448.0  
Crystal size/mm3  0.275 × 0.205 × 0.157  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/° 10.068 to 134.11  
Index ranges  -9 ≤ h ≤ 7, -20 ≤ k ≤ 20, -11 ≤ l ≤ 10  
Reflections collected  3983  
Independent reflections  2108 [Rint = 0.0143, Rsigma = 0.0219] 
Data/restraints/parameters  2108/0/217  
Goodness-of-fit on F2  1.042  
Final R indexes [I>=2σ (I)]  R1 = 0.0337, wR2 = 0.0835  
Final R indexes [all data]  R1 = 0.0390, wR2 = 0.0881  
Largest diff. peak/hole / e Å-3  0.28/-0.16  
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Appendix B: Crystal data and structure refinement for 111. 
 
Crystal data and structure refinement for 111.  
Identification code  pac1905  
Empirical formula  C17H19IN4O6  
Formula weight  502.26  
Temperature/K  110.00(14)  
Crystal system  monoclinic  
Space group  I2/a  
a/Å  11.4622(4)  
b/Å  11.7685(4)  
c/Å  28.4710(10)  
α/°  90  
β/°  97.469(3)  
γ/°  90  
Volume/Å3  3808.0(2)  
Z  8  
ρcalcg/cm3  1.752  
μ/mm-1  13.604  
F(000)  2000.0  
102 | P a g e  
 
Crystal size/mm3  0.089 × 0.063 × 0.009  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/° 8.14 to 134.128  
Index ranges  -13 ≤ h ≤ 13, -10 ≤ k ≤ 14, -26 ≤ l ≤ 34 
Reflections collected  6841  
Independent reflections  3395 [Rint = 0.0275, Rsigma = 0.0373]  
Data/restraints/parameters  3395/7/304  
Goodness-of-fit on F2  1.230  
Final R indexes [I>=2σ (I)]  R1 = 0.0571, wR2 = 0.1082  
Final R indexes [all data]  R1 = 0.0658, wR2 = 0.1117  
Largest diff. peak/hole / e Å-3  0.97/-0.80  
 
Data collected, solved and refined by Adrian C Whitwood 
  
 
 
 
 
 
 
